Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pparg
|
ENSMUSG00000000440.6 | peroxisome proliferator activated receptor gamma |
Rxrg
|
ENSMUSG00000015843.4 | retinoid X receptor gamma |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_115382869_115383020 | Pparg | 755 | 0.708445 | 0.45 | 5.7e-04 | Click! |
chr6_115421786_115421937 | Pparg | 205 | 0.947151 | 0.41 | 1.8e-03 | Click! |
chr6_115367322_115367473 | Pparg | 5047 | 0.250448 | 0.39 | 2.9e-03 | Click! |
chr6_115421049_115421200 | Pparg | 942 | 0.601961 | 0.33 | 1.5e-02 | Click! |
chr6_115424623_115424776 | Pparg | 2633 | 0.292021 | 0.33 | 1.5e-02 | Click! |
chr1_167598422_167598856 | Rxrg | 159 | 0.971453 | -0.81 | 7.4e-14 | Click! |
chr1_167598220_167598410 | Rxrg | 69 | 0.983436 | -0.79 | 6.8e-13 | Click! |
chr1_167608265_167608743 | Rxrg | 9805 | 0.265788 | -0.74 | 7.3e-11 | Click! |
chr1_167644926_167645146 | Rxrg | 26727 | 0.208992 | -0.72 | 8.0e-10 | Click! |
chr1_167583775_167584240 | Rxrg | 14377 | 0.252285 | -0.70 | 2.6e-09 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_169997850_169998483 | 46.75 |
Gm15247 |
predicted gene 15247 |
11227 |
0.14 |
chrY_90771840_90772811 | 45.49 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr8_104374837_104375423 | 44.36 |
Gm45877 |
predicted gene 45877 |
11462 |
0.09 |
chr5_114968675_114969360 | 39.53 |
Hnf1aos2 |
HNF1 homeobox A, opposite strand 2 |
194 |
0.52 |
chr8_117718550_117718744 | 39.49 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
2289 |
0.22 |
chr16_4012853_4013176 | 37.33 |
Slx4 |
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae) |
9244 |
0.1 |
chr10_127508848_127510720 | 34.90 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr8_46387049_46387206 | 34.35 |
Gm45253 |
predicted gene 45253 |
1239 |
0.4 |
chr17_49305203_49305406 | 33.72 |
Gm17830 |
predicted gene, 17830 |
6937 |
0.19 |
chr14_76817069_76817629 | 33.57 |
Gm48968 |
predicted gene, 48968 |
15472 |
0.18 |
chr12_81189673_81190004 | 33.00 |
Mir3067 |
microRNA 3067 |
23687 |
0.18 |
chr7_115845008_115845308 | 31.19 |
Sox6 |
SRY (sex determining region Y)-box 6 |
947 |
0.7 |
chr4_135958432_135958739 | 31.08 |
Hmgcl |
3-hydroxy-3-methylglutaryl-Coenzyme A lyase |
1142 |
0.29 |
chr16_95682683_95682992 | 31.02 |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
19238 |
0.21 |
chr3_121867304_121867472 | 30.99 |
Gm42593 |
predicted gene 42593 |
4546 |
0.19 |
chr1_154034260_154034430 | 29.55 |
Gm28286 |
predicted gene 28286 |
44 |
0.97 |
chr11_98446586_98447075 | 28.75 |
Grb7 |
growth factor receptor bound protein 7 |
4 |
0.95 |
chr2_160619427_160619728 | 28.33 |
Gm14221 |
predicted gene 14221 |
394 |
0.83 |
chr12_83579151_83579469 | 28.09 |
Zfyve1 |
zinc finger, FYVE domain containing 1 |
16377 |
0.14 |
chr16_8603622_8604209 | 27.78 |
Abat |
4-aminobutyrate aminotransferase |
8963 |
0.12 |
chr15_85787521_85787809 | 27.68 |
Ppara |
peroxisome proliferator activated receptor alpha |
15451 |
0.13 |
chr7_17058026_17058724 | 27.52 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
159 |
0.9 |
chr3_96875239_96875430 | 27.49 |
Gpr89 |
G protein-coupled receptor 89 |
874 |
0.48 |
chr4_134759700_134760317 | 27.20 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
8016 |
0.2 |
chr19_4024416_4024567 | 27.14 |
Gstp1 |
glutathione S-transferase, pi 1 |
11502 |
0.06 |
chr12_72535708_72536908 | 26.86 |
Pcnx4 |
pecanex homolog 4 |
75 |
0.97 |
chr9_61370339_61371660 | 26.64 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr15_98608664_98610204 | 26.60 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr8_94962299_94962469 | 26.46 |
Gm10286 |
predicted gene 10286 |
7370 |
0.12 |
chr4_141750503_141750994 | 26.43 |
Agmat |
agmatine ureohydrolase (agmatinase) |
4076 |
0.15 |
chr3_121867514_121867696 | 26.21 |
Gm42593 |
predicted gene 42593 |
4763 |
0.19 |
chr8_94733906_94734089 | 26.19 |
Ccl22 |
chemokine (C-C motif) ligand 22 |
11593 |
0.12 |
chr11_51768365_51768797 | 26.11 |
Sar1b |
secretion associated Ras related GTPase 1B |
4887 |
0.17 |
chr2_155604966_155605247 | 25.96 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6106 |
0.08 |
chr15_83223251_83223918 | 25.93 |
A4galt |
alpha 1,4-galactosyltransferase |
28145 |
0.1 |
chr3_84135410_84135679 | 25.68 |
Mnd1 |
meiotic nuclear divisions 1 |
20242 |
0.18 |
chr17_34898151_34899707 | 25.37 |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
25 |
0.87 |
chr15_99835240_99835516 | 25.29 |
Lima1 |
LIM domain and actin binding 1 |
15235 |
0.08 |
chr11_90363830_90364151 | 24.63 |
Hlf |
hepatic leukemia factor |
17945 |
0.24 |
chr5_137530580_137532081 | 24.42 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr4_141347349_141347551 | 24.16 |
Gm13074 |
predicted gene 13074 |
364 |
0.7 |
chr4_41096273_41096533 | 23.99 |
Aqp3 |
aquaporin 3 |
1780 |
0.23 |
chr9_110343931_110344181 | 23.34 |
Scap |
SREBF chaperone |
143 |
0.93 |
chr3_89136366_89136871 | 23.09 |
Pklr |
pyruvate kinase liver and red blood cell |
5 |
0.94 |
chr7_127768560_127769629 | 23.07 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr11_77771976_77772139 | 23.06 |
Myo18a |
myosin XVIIIA |
94 |
0.96 |
chr2_25156337_25156493 | 23.02 |
Gm13387 |
predicted gene 13387 |
11019 |
0.07 |
chr16_38282619_38282812 | 23.00 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
12109 |
0.14 |
chr6_5509786_5510231 | 22.95 |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
13699 |
0.28 |
chr19_43918832_43919020 | 22.74 |
Gm50217 |
predicted gene, 50217 |
1547 |
0.3 |
chr1_166002288_166003185 | 22.73 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr16_49839698_49840015 | 22.70 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
15510 |
0.24 |
chr3_88532663_88533971 | 22.60 |
Mex3a |
mex3 RNA binding family member A |
922 |
0.31 |
chr6_71199690_71199907 | 22.32 |
Fabp1 |
fatty acid binding protein 1, liver |
29 |
0.96 |
chr16_21828247_21828594 | 22.15 |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
2478 |
0.18 |
chr6_86637175_86637482 | 22.10 |
Asprv1 |
aspartic peptidase, retroviral-like 1 |
9164 |
0.11 |
chr3_84460630_84461321 | 22.01 |
Fhdc1 |
FH2 domain containing 1 |
7212 |
0.24 |
chr2_153492229_153493481 | 21.94 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr3_117061396_117061605 | 21.81 |
1700061I17Rik |
RIKEN cDNA 1700061I17 gene |
16265 |
0.17 |
chr1_185515526_185516243 | 21.57 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
18496 |
0.17 |
chr10_81092585_81092876 | 21.55 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
155 |
0.88 |
chr1_180821249_180821410 | 21.43 |
H3f3a |
H3.3 histone A |
7386 |
0.1 |
chr8_126774862_126775184 | 21.41 |
Gm45805 |
predicted gene 45805 |
16689 |
0.22 |
chr10_127512528_127514054 | 21.27 |
Ndufa4l2 |
Ndufa4, mitochondrial complex associated like 2 |
1676 |
0.21 |
chr5_36724217_36724614 | 21.27 |
Gm43701 |
predicted gene 43701 |
24203 |
0.11 |
chr1_168287679_168288893 | 20.92 |
Gm37524 |
predicted gene, 37524 |
49385 |
0.16 |
chr4_132066130_132066475 | 20.87 |
Epb41 |
erythrocyte membrane protein band 4.1 |
5795 |
0.12 |
chr2_84810833_84811663 | 20.84 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
5019 |
0.11 |
chr19_55260518_55260669 | 20.82 |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
7224 |
0.18 |
chr5_30152070_30152318 | 20.78 |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
2651 |
0.17 |
chr4_115513954_115514105 | 20.69 |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
4235 |
0.14 |
chr7_100500401_100501097 | 20.65 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
2403 |
0.14 |
chr11_79992495_79993374 | 20.60 |
Suz12 |
SUZ12 polycomb repressive complex 2 subunit |
172 |
0.95 |
chr3_131263877_131264074 | 20.53 |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
8049 |
0.16 |
chr2_27560909_27561138 | 20.49 |
Gm13421 |
predicted gene 13421 |
20594 |
0.14 |
chrX_101299536_101300464 | 20.36 |
Nlgn3 |
neuroligin 3 |
474 |
0.66 |
chr5_73311488_73311911 | 20.34 |
Gm42732 |
predicted gene 42732 |
335 |
0.78 |
chr11_98750501_98751849 | 20.31 |
Thra |
thyroid hormone receptor alpha |
2411 |
0.15 |
chr11_98941353_98942362 | 20.30 |
Rara |
retinoic acid receptor, alpha |
2145 |
0.18 |
chr11_78073909_78074294 | 20.29 |
Mir451b |
microRNA 451b |
860 |
0.24 |
chr11_97435561_97436362 | 20.24 |
Arhgap23 |
Rho GTPase activating protein 23 |
324 |
0.87 |
chr3_52502231_52502591 | 20.23 |
Gm30173 |
predicted gene, 30173 |
14553 |
0.23 |
chr11_97427734_97428829 | 20.22 |
Arhgap23 |
Rho GTPase activating protein 23 |
8004 |
0.16 |
chr1_191641396_191641769 | 20.20 |
Gm37349 |
predicted gene, 37349 |
43935 |
0.11 |
chr7_123462053_123462460 | 20.13 |
Aqp8 |
aquaporin 8 |
35 |
0.98 |
chr13_95491376_95491652 | 20.09 |
S100z |
S100 calcium binding protein, zeta |
12793 |
0.15 |
chr11_102241268_102241471 | 20.08 |
Hrob |
homologous recombination factor with OB-fold |
7513 |
0.09 |
chr12_80088231_80088408 | 19.91 |
Gm47752 |
predicted gene, 47752 |
3048 |
0.18 |
chr10_128459263_128459897 | 19.88 |
Smarcc2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 |
76 |
0.89 |
chr19_4593871_4594048 | 19.86 |
Pcx |
pyruvate carboxylase |
387 |
0.78 |
chr1_134055136_134055454 | 19.85 |
Fmod |
fibromodulin |
17799 |
0.12 |
chr7_80129382_80129580 | 19.74 |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
14089 |
0.1 |
chr7_120875026_120875242 | 19.70 |
Gm15774 |
predicted gene 15774 |
164 |
0.89 |
chr7_141343308_141343459 | 19.68 |
Eps8l2 |
EPS8-like 2 |
727 |
0.42 |
chr8_10854830_10855021 | 19.68 |
Gm32540 |
predicted gene, 32540 |
11261 |
0.12 |
chr4_138342781_138342970 | 19.66 |
Cda |
cytidine deaminase |
774 |
0.5 |
chr8_23246177_23246339 | 19.64 |
Golga7 |
golgi autoantigen, golgin subfamily a, 7 |
1080 |
0.39 |
chr1_74196703_74196896 | 19.46 |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
2168 |
0.19 |
chr5_145222933_145223234 | 19.44 |
Zfp655 |
zinc finger protein 655 |
8632 |
0.1 |
chr5_36713069_36713508 | 19.35 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
17264 |
0.12 |
chr7_103865767_103866083 | 19.29 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
12709 |
0.06 |
chr18_68274714_68274873 | 19.17 |
Mir7219 |
microRNA 7219 |
13820 |
0.15 |
chr5_139738871_139739112 | 19.06 |
Micall2 |
MICAL-like 2 |
2655 |
0.2 |
chr10_68446597_68447155 | 18.82 |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
78891 |
0.09 |
chr4_101674751_101675082 | 18.75 |
Leprot |
leptin receptor overlapping transcript |
27123 |
0.18 |
chr10_80332200_80332394 | 18.74 |
Reep6 |
receptor accessory protein 6 |
2095 |
0.11 |
chr6_113656820_113657173 | 18.67 |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
11854 |
0.07 |
chr6_38881573_38881724 | 18.62 |
Hipk2 |
homeodomain interacting protein kinase 2 |
5483 |
0.22 |
chr7_90059784_90060230 | 18.49 |
Gm44861 |
predicted gene 44861 |
17310 |
0.12 |
chr7_99214872_99215226 | 18.46 |
Gm45012 |
predicted gene 45012 |
12683 |
0.12 |
chr19_53554399_53554765 | 18.45 |
Gm50394 |
predicted gene, 50394 |
24927 |
0.11 |
chr8_33902805_33903061 | 18.42 |
Rbpms |
RNA binding protein gene with multiple splicing |
11169 |
0.17 |
chr5_144317459_144317816 | 18.40 |
Baiap2l1 |
BAI1-associated protein 2-like 1 |
28730 |
0.12 |
chr2_110305646_110305856 | 18.37 |
Bbox1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) |
10 |
0.98 |
chr6_88253935_88254491 | 18.28 |
1700031F10Rik |
RIKEN cDNA 1700031F10 gene |
28535 |
0.12 |
chr4_8704320_8704502 | 18.28 |
Chd7 |
chromodomain helicase DNA binding protein 7 |
5929 |
0.27 |
chr2_128612336_128612537 | 18.26 |
Gm39929 |
predicted gene, 39929 |
2806 |
0.17 |
chr9_120601947_120602150 | 18.25 |
Gm39456 |
predicted gene, 39456 |
12700 |
0.12 |
chr3_89133890_89134151 | 18.21 |
Pklr |
pyruvate kinase liver and red blood cell |
2122 |
0.13 |
chr7_34969107_34969361 | 18.17 |
Pepd |
peptidase D |
49 |
0.97 |
chr9_15535486_15535776 | 18.08 |
Smco4 |
single-pass membrane protein with coiled-coil domains 4 |
14772 |
0.16 |
chr11_102364651_102365006 | 18.07 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
419 |
0.72 |
chr11_32283952_32284215 | 18.03 |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
272 |
0.83 |
chr2_173050678_173051259 | 18.02 |
Gm14453 |
predicted gene 14453 |
16388 |
0.13 |
chr19_56601875_56602283 | 18.01 |
Nhlrc2 |
NHL repeat containing 2 |
31282 |
0.15 |
chr5_134915452_134915620 | 17.92 |
Cldn13 |
claudin 13 |
10 |
0.94 |
chr6_118758618_118758929 | 17.84 |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
799 |
0.74 |
chr11_35732476_35732633 | 17.79 |
Pank3 |
pantothenate kinase 3 |
36930 |
0.14 |
chr14_8016325_8016594 | 17.78 |
Abhd6 |
abhydrolase domain containing 6 |
13493 |
0.17 |
chr17_84895487_84895638 | 17.78 |
Gm49982 |
predicted gene, 49982 |
7007 |
0.18 |
chr2_170459761_170460089 | 17.77 |
Gm14269 |
predicted gene 14269 |
3894 |
0.19 |
chr1_24613351_24614205 | 17.57 |
Gm28437 |
predicted gene 28437 |
193 |
0.69 |
chr2_153495771_153496762 | 17.56 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
3476 |
0.22 |
chr5_64326426_64326733 | 17.53 |
Gm6044 |
predicted gene 6044 |
6323 |
0.16 |
chr16_22891950_22892305 | 17.46 |
Ahsg |
alpha-2-HS-glycoprotein |
82 |
0.95 |
chr11_94334456_94334620 | 17.46 |
Ankrd40 |
ankyrin repeat domain 40 |
1085 |
0.44 |
chr10_78004632_78004848 | 17.41 |
Pfkl |
phosphofructokinase, liver, B-type |
3261 |
0.14 |
chr8_70665742_70665917 | 17.38 |
Pgpep1 |
pyroglutamyl-peptidase I |
5441 |
0.09 |
chr7_45575109_45575269 | 17.38 |
0610005C13Rik |
RIKEN cDNA 0610005C13 gene |
5 |
0.49 |
chr6_91193217_91193368 | 17.35 |
4930402H05Rik |
RIKEN cDNA 4930402H05 gene |
16752 |
0.12 |
chr11_75926900_75927103 | 17.35 |
Rph3al |
rabphilin 3A-like (without C2 domains) |
1110 |
0.53 |
chr9_65304301_65304574 | 17.31 |
Clpx |
caseinolytic mitochondrial matrix peptidase chaperone subunit |
5715 |
0.11 |
chr8_69063512_69063903 | 17.31 |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
11801 |
0.15 |
chr4_101393109_101393260 | 17.30 |
Gm12798 |
predicted gene 12798 |
9897 |
0.12 |
chr15_102017591_102018334 | 17.26 |
Krt18 |
keratin 18 |
10218 |
0.11 |
chr8_114777748_114777931 | 17.23 |
Wwox |
WW domain-containing oxidoreductase |
65672 |
0.12 |
chr3_137972507_137972950 | 17.20 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
8802 |
0.13 |
chr18_74392971_74393328 | 17.20 |
Gm8986 |
predicted gene 8986 |
7459 |
0.18 |
chr17_5893214_5893395 | 17.08 |
Gm8376 |
predicted gene 8376 |
45783 |
0.1 |
chr10_70127259_70127423 | 17.00 |
Ccdc6 |
coiled-coil domain containing 6 |
30220 |
0.2 |
chr17_6018245_6018730 | 16.97 |
Synj2 |
synaptojanin 2 |
4938 |
0.19 |
chr11_79771332_79771811 | 16.92 |
9130204K15Rik |
RIKEN cDNA 9130204K15 gene |
11316 |
0.16 |
chr4_150854030_150854262 | 16.87 |
Errfi1 |
ERBB receptor feedback inhibitor 1 |
227 |
0.82 |
chr2_38286754_38287566 | 16.85 |
Dennd1a |
DENN/MADD domain containing 1A |
28 |
0.97 |
chr11_98394957_98395469 | 16.78 |
Pgap3 |
post-GPI attachment to proteins 3 |
3141 |
0.11 |
chr11_51767849_51768134 | 16.76 |
Sar1b |
secretion associated Ras related GTPase 1B |
4297 |
0.17 |
chr9_53607384_53607535 | 16.72 |
Acat1 |
acetyl-Coenzyme A acetyltransferase 1 |
2871 |
0.2 |
chr6_144652995_144653148 | 16.67 |
Sox5it |
SRY (sex determining region Y)-box 5, intronic transcript |
19649 |
0.18 |
chr1_88044901_88045120 | 16.64 |
AC087801.1 |
UDP glycosyltransferase 1 family (Ytg1) pseudogene |
7410 |
0.08 |
chr19_6969291_6970359 | 16.61 |
Plcb3 |
phospholipase C, beta 3 |
11 |
0.93 |
chr13_97295465_97295787 | 16.56 |
C430039J16Rik |
RIKEN cDNA C430039J16 gene |
12443 |
0.19 |
chr5_135013108_135013523 | 16.55 |
Abhd11os |
abhydrolase domain containing 11, opposite strand |
62 |
0.92 |
chr6_121143507_121143849 | 16.53 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
12679 |
0.14 |
chr11_120852104_120852370 | 16.53 |
Gm11773 |
predicted gene 11773 |
21208 |
0.09 |
chr10_77134600_77134762 | 16.51 |
Gm7775 |
predicted gene 7775 |
2419 |
0.28 |
chr7_25132999_25133993 | 16.48 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
984 |
0.41 |
chr5_103738192_103738402 | 16.42 |
Aff1 |
AF4/FMR2 family, member 1 |
15865 |
0.19 |
chr5_96919678_96919932 | 16.38 |
Gm8013 |
predicted gene 8013 |
1467 |
0.22 |
chr3_79144987_79146081 | 16.37 |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
341 |
0.91 |
chr19_34819633_34819818 | 16.34 |
Mir107 |
microRNA 107 |
1048 |
0.43 |
chr8_46404279_46404464 | 16.32 |
Gm45253 |
predicted gene 45253 |
18483 |
0.13 |
chr4_115555534_115555685 | 16.30 |
Cyp4a31 |
cytochrome P450, family 4, subfamily a, polypeptide 31 |
8040 |
0.12 |
chr15_83375189_83375572 | 16.20 |
1700001L05Rik |
RIKEN cDNA 1700001L05 gene |
8098 |
0.14 |
chr12_84384900_84385094 | 16.18 |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
413 |
0.74 |
chr1_89026213_89026430 | 16.17 |
1700067G17Rik |
RIKEN cDNA 1700067G17 gene |
10208 |
0.18 |
chr11_95777553_95777757 | 16.14 |
Polr2k-ps |
polymerase (RNA) II (DNA directed) polypeptide K, pseudogene |
16164 |
0.12 |
chr16_21790432_21790733 | 16.14 |
Ehhadh |
enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase |
2775 |
0.16 |
chr2_75705192_75705343 | 16.14 |
E030042O20Rik |
RIKEN cDNA E030042O20 gene |
497 |
0.49 |
chr12_111443494_111443821 | 16.09 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
667 |
0.58 |
chr7_123353967_123354476 | 16.08 |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
15563 |
0.17 |
chr12_83454842_83455211 | 16.07 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
15106 |
0.2 |
chr13_101545392_101545560 | 16.06 |
Gm47533 |
predicted gene, 47533 |
270 |
0.89 |
chr4_134067433_134068149 | 16.05 |
Crybg2 |
crystallin beta-gamma domain containing 2 |
661 |
0.56 |
chr6_124481595_124482129 | 16.04 |
C1rl |
complement component 1, r subcomponent-like |
11251 |
0.09 |
chr1_185469514_185469706 | 15.99 |
Gm2061 |
predicted gene 2061 |
14042 |
0.12 |
chr3_60098632_60098826 | 15.93 |
Sucnr1 |
succinate receptor 1 |
16827 |
0.18 |
chr2_167589238_167589449 | 15.91 |
Gm11475 |
predicted gene 11475 |
2052 |
0.21 |
chr19_34496394_34496730 | 15.89 |
Lipa |
lysosomal acid lipase A |
5291 |
0.15 |
chr7_99804159_99804317 | 15.89 |
F730035P03Rik |
RIKEN cDNA F730035P03 gene |
22699 |
0.1 |
chr16_32509015_32509568 | 15.88 |
Zdhhc19 |
zinc finger, DHHC domain containing 19 |
9680 |
0.13 |
chr5_65350579_65350731 | 15.85 |
Klb |
klotho beta |
2247 |
0.19 |
chr1_181334651_181334972 | 15.83 |
Cnih3 |
cornichon family AMPA receptor auxiliary protein 3 |
17817 |
0.15 |
chr11_89003182_89003345 | 15.82 |
Trim25 |
tripartite motif-containing 25 |
3887 |
0.13 |
chr17_47909349_47909983 | 15.80 |
Gm15556 |
predicted gene 15556 |
12712 |
0.13 |
chr11_8504165_8504360 | 15.77 |
Tns3 |
tensin 3 |
35587 |
0.23 |
chr7_19685403_19685697 | 15.73 |
Apoc4 |
apolipoprotein C-IV |
4071 |
0.08 |
chr11_12190636_12190792 | 15.72 |
Gm12001 |
predicted gene 12001 |
62716 |
0.13 |
chr4_150220682_150221014 | 15.69 |
Gm13094 |
predicted gene 13094 |
7187 |
0.14 |
chr7_45897196_45897738 | 15.69 |
Tmem143 |
transmembrane protein 143 |
44 |
0.9 |
chr11_73326462_73326649 | 15.67 |
Aspa |
aspartoacylase |
78 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.2 | 48.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
13.2 | 39.6 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
13.0 | 51.9 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
12.7 | 63.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
12.0 | 60.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
11.3 | 33.8 | GO:0042908 | xenobiotic transport(GO:0042908) |
10.5 | 31.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
10.1 | 30.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
9.5 | 19.1 | GO:0002432 | granuloma formation(GO:0002432) |
9.3 | 27.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
9.1 | 36.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
9.0 | 27.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
8.5 | 25.6 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
8.3 | 24.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
8.2 | 16.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
8.2 | 49.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
8.2 | 24.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
8.1 | 8.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
8.0 | 16.0 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
8.0 | 40.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
7.8 | 7.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
7.6 | 22.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
7.6 | 22.8 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
7.5 | 22.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
7.4 | 22.2 | GO:0008228 | opsonization(GO:0008228) |
7.2 | 28.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
7.2 | 14.3 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
7.1 | 21.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
7.1 | 7.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
7.1 | 21.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
7.0 | 21.1 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
7.0 | 20.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
7.0 | 27.9 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
7.0 | 62.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
6.8 | 27.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
6.8 | 20.3 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
6.8 | 20.3 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
6.7 | 20.1 | GO:0032782 | bile acid secretion(GO:0032782) |
6.7 | 6.7 | GO:0070627 | ferrous iron import(GO:0070627) |
6.6 | 19.9 | GO:0002086 | diaphragm contraction(GO:0002086) |
6.6 | 33.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
6.5 | 19.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
6.5 | 32.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
6.5 | 19.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
6.4 | 25.7 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
6.4 | 19.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
6.3 | 12.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
6.3 | 37.8 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
6.3 | 18.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
6.3 | 18.8 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
6.3 | 18.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
6.3 | 18.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
6.2 | 55.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
6.2 | 18.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
6.1 | 30.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
6.1 | 30.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
6.1 | 12.1 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
6.0 | 18.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
6.0 | 6.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
6.0 | 30.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
6.0 | 23.9 | GO:0006083 | acetate metabolic process(GO:0006083) |
5.9 | 5.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
5.9 | 47.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
5.9 | 5.9 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
5.9 | 17.6 | GO:0032439 | endosome localization(GO:0032439) |
5.8 | 23.3 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
5.8 | 17.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
5.8 | 46.4 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
5.7 | 28.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
5.6 | 16.9 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
5.6 | 28.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
5.6 | 16.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
5.6 | 16.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
5.6 | 44.8 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
5.5 | 22.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
5.5 | 16.4 | GO:0046104 | thymidine metabolic process(GO:0046104) |
5.5 | 5.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
5.4 | 16.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
5.4 | 16.3 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
5.4 | 59.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
5.4 | 16.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
5.4 | 64.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
5.4 | 21.5 | GO:0019532 | oxalate transport(GO:0019532) |
5.4 | 10.7 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
5.3 | 53.4 | GO:0034063 | stress granule assembly(GO:0034063) |
5.3 | 16.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
5.3 | 26.6 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
5.3 | 5.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
5.3 | 15.9 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
5.3 | 15.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
5.3 | 5.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
5.3 | 21.0 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
5.2 | 20.8 | GO:0015793 | glycerol transport(GO:0015793) |
5.2 | 10.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
5.2 | 20.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
5.0 | 20.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
5.0 | 15.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
5.0 | 25.1 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
5.0 | 5.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
5.0 | 10.0 | GO:0036394 | amylase secretion(GO:0036394) |
5.0 | 19.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
5.0 | 69.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
5.0 | 14.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
5.0 | 29.7 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
4.9 | 14.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
4.9 | 29.1 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
4.8 | 19.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
4.8 | 9.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
4.8 | 28.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
4.7 | 19.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
4.7 | 23.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
4.7 | 23.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
4.7 | 14.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
4.7 | 79.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
4.6 | 13.9 | GO:1902896 | terminal web assembly(GO:1902896) |
4.6 | 13.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
4.6 | 27.6 | GO:0048069 | eye pigmentation(GO:0048069) |
4.6 | 18.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
4.6 | 41.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
4.6 | 50.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
4.5 | 9.0 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
4.5 | 17.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
4.5 | 4.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
4.5 | 17.8 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
4.4 | 4.4 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
4.4 | 8.8 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
4.4 | 8.8 | GO:0060056 | mammary gland involution(GO:0060056) |
4.4 | 8.8 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
4.4 | 4.4 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
4.4 | 8.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
4.4 | 13.1 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
4.4 | 4.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
4.4 | 34.9 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
4.3 | 8.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
4.3 | 12.9 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
4.3 | 25.9 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
4.3 | 17.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.3 | 38.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
4.3 | 17.0 | GO:0009597 | detection of virus(GO:0009597) |
4.3 | 97.9 | GO:0048821 | erythrocyte development(GO:0048821) |
4.3 | 8.5 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
4.2 | 12.7 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
4.2 | 12.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
4.2 | 21.1 | GO:0006534 | cysteine metabolic process(GO:0006534) |
4.2 | 16.9 | GO:0015886 | heme transport(GO:0015886) |
4.2 | 4.2 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
4.2 | 16.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
4.2 | 37.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
4.2 | 12.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
4.2 | 21.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
4.2 | 8.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
4.2 | 20.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
4.2 | 8.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
4.2 | 8.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
4.1 | 4.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
4.1 | 4.1 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
4.1 | 12.2 | GO:0008050 | female courtship behavior(GO:0008050) |
4.1 | 8.1 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
4.1 | 4.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
4.1 | 8.1 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
4.0 | 12.1 | GO:0040031 | snRNA modification(GO:0040031) |
4.0 | 28.3 | GO:0046060 | dATP metabolic process(GO:0046060) |
4.0 | 4.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
4.0 | 8.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
4.0 | 20.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
4.0 | 12.1 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
4.0 | 12.0 | GO:0030242 | pexophagy(GO:0030242) |
4.0 | 4.0 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
4.0 | 4.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
4.0 | 55.5 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
4.0 | 4.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
4.0 | 27.7 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
3.9 | 11.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
3.9 | 7.9 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
3.9 | 3.9 | GO:0006848 | pyruvate transport(GO:0006848) |
3.9 | 11.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
3.9 | 11.7 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
3.9 | 11.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
3.9 | 15.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.9 | 11.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.9 | 65.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
3.8 | 11.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
3.8 | 7.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.8 | 23.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
3.8 | 11.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
3.8 | 11.5 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
3.8 | 26.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
3.8 | 3.8 | GO:0036258 | multivesicular body assembly(GO:0036258) |
3.8 | 26.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
3.8 | 15.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
3.8 | 3.8 | GO:0032898 | neurotrophin production(GO:0032898) |
3.8 | 30.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
3.7 | 30.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
3.7 | 48.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
3.7 | 14.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.7 | 33.5 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
3.7 | 22.3 | GO:0051639 | actin filament network formation(GO:0051639) |
3.7 | 11.2 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
3.7 | 14.8 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
3.7 | 3.7 | GO:0050904 | diapedesis(GO:0050904) |
3.7 | 11.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
3.7 | 11.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
3.7 | 18.5 | GO:0018904 | ether metabolic process(GO:0018904) |
3.7 | 11.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
3.7 | 11.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
3.7 | 18.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
3.7 | 18.4 | GO:0042737 | drug catabolic process(GO:0042737) |
3.7 | 11.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
3.7 | 11.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
3.7 | 7.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
3.7 | 7.4 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
3.7 | 14.7 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
3.7 | 18.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
3.7 | 18.3 | GO:0097459 | iron ion import into cell(GO:0097459) |
3.7 | 21.9 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
3.7 | 29.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
3.7 | 14.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.6 | 3.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
3.6 | 7.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
3.6 | 25.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
3.6 | 10.8 | GO:0097286 | iron ion import(GO:0097286) |
3.6 | 10.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
3.6 | 10.8 | GO:0048769 | sarcomerogenesis(GO:0048769) |
3.6 | 10.8 | GO:0006116 | NADH oxidation(GO:0006116) |
3.6 | 3.6 | GO:0015705 | iodide transport(GO:0015705) |
3.6 | 14.4 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
3.6 | 35.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
3.6 | 10.7 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
3.6 | 7.1 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
3.6 | 3.6 | GO:0003032 | detection of oxygen(GO:0003032) |
3.5 | 7.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
3.5 | 17.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
3.5 | 24.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
3.5 | 14.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
3.5 | 3.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.5 | 28.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
3.5 | 3.5 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
3.5 | 10.4 | GO:0000087 | mitotic M phase(GO:0000087) |
3.5 | 10.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
3.5 | 3.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
3.5 | 17.3 | GO:0072553 | terminal button organization(GO:0072553) |
3.4 | 6.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
3.4 | 3.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
3.4 | 3.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
3.4 | 10.3 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
3.4 | 6.8 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
3.4 | 23.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
3.4 | 17.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
3.4 | 6.8 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
3.4 | 10.2 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
3.4 | 23.7 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
3.4 | 3.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
3.4 | 16.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
3.3 | 10.0 | GO:0021553 | olfactory nerve development(GO:0021553) |
3.3 | 60.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
3.3 | 3.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
3.3 | 3.3 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
3.3 | 43.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
3.3 | 9.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
3.3 | 13.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
3.3 | 3.3 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
3.3 | 6.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
3.3 | 29.4 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
3.3 | 6.5 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
3.3 | 3.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
3.3 | 22.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
3.3 | 6.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.3 | 13.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
3.3 | 16.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
3.3 | 13.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
3.2 | 13.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
3.2 | 9.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
3.2 | 9.7 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
3.2 | 3.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
3.2 | 9.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
3.2 | 16.0 | GO:1904970 | brush border assembly(GO:1904970) |
3.2 | 3.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) |
3.2 | 22.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
3.2 | 6.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
3.2 | 6.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
3.2 | 3.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
3.2 | 9.5 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
3.2 | 12.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
3.2 | 3.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
3.1 | 15.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
3.1 | 12.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.1 | 6.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
3.1 | 3.1 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
3.1 | 6.3 | GO:0006868 | glutamine transport(GO:0006868) |
3.1 | 3.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
3.1 | 9.4 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
3.1 | 6.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
3.1 | 3.1 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
3.1 | 3.1 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
3.1 | 18.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
3.1 | 6.2 | GO:0006562 | proline catabolic process(GO:0006562) |
3.1 | 9.3 | GO:0061511 | centriole elongation(GO:0061511) |
3.1 | 12.3 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
3.0 | 9.1 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
3.0 | 9.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.0 | 9.1 | GO:0001555 | oocyte growth(GO:0001555) |
3.0 | 12.2 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
3.0 | 12.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
3.0 | 9.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
3.0 | 3.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
3.0 | 12.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
3.0 | 12.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
3.0 | 15.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
3.0 | 12.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
3.0 | 3.0 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
3.0 | 6.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.0 | 3.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
3.0 | 11.9 | GO:0002317 | plasma cell differentiation(GO:0002317) |
3.0 | 17.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
3.0 | 5.9 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
2.9 | 29.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
2.9 | 8.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
2.9 | 8.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.9 | 8.8 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.9 | 8.7 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.9 | 11.6 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
2.9 | 2.9 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
2.9 | 5.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
2.9 | 25.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
2.9 | 8.6 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
2.9 | 43.1 | GO:0051923 | sulfation(GO:0051923) |
2.9 | 8.6 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.9 | 14.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.8 | 11.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
2.8 | 19.9 | GO:0070255 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
2.8 | 5.7 | GO:0002159 | desmosome assembly(GO:0002159) |
2.8 | 11.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.8 | 14.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.8 | 2.8 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.8 | 2.8 | GO:0071280 | cellular response to copper ion(GO:0071280) |
2.8 | 5.6 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
2.8 | 5.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
2.8 | 8.4 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
2.8 | 11.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.8 | 19.7 | GO:0036010 | protein localization to endosome(GO:0036010) |
2.8 | 11.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
2.8 | 19.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
2.8 | 52.7 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.8 | 5.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
2.8 | 2.8 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
2.7 | 8.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.7 | 16.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.7 | 10.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
2.7 | 8.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
2.7 | 27.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.7 | 21.6 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
2.7 | 13.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.7 | 10.8 | GO:0009838 | abscission(GO:0009838) |
2.7 | 13.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
2.7 | 5.4 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
2.7 | 26.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
2.7 | 8.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.7 | 16.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
2.7 | 18.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
2.7 | 8.0 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
2.7 | 8.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
2.7 | 18.7 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
2.7 | 2.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
2.7 | 5.3 | GO:0031033 | myosin filament organization(GO:0031033) |
2.7 | 10.6 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
2.7 | 5.3 | GO:0010543 | regulation of platelet activation(GO:0010543) |
2.7 | 10.6 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.6 | 5.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.6 | 13.2 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
2.6 | 7.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
2.6 | 10.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
2.6 | 10.5 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
2.6 | 26.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
2.6 | 5.2 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
2.6 | 2.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
2.6 | 20.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
2.6 | 20.8 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
2.6 | 2.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
2.6 | 2.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
2.6 | 15.5 | GO:0030223 | neutrophil differentiation(GO:0030223) |
2.6 | 15.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.6 | 23.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
2.6 | 20.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.6 | 10.2 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
2.5 | 2.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.5 | 2.5 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
2.5 | 12.7 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
2.5 | 27.9 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
2.5 | 2.5 | GO:0006833 | water transport(GO:0006833) |
2.5 | 2.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
2.5 | 2.5 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
2.5 | 2.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
2.5 | 17.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
2.5 | 7.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
2.5 | 40.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
2.5 | 5.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
2.5 | 10.1 | GO:0044845 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
2.5 | 5.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
2.5 | 7.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.5 | 5.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.5 | 2.5 | GO:0015747 | urate transport(GO:0015747) |
2.5 | 12.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.5 | 10.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
2.5 | 2.5 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
2.5 | 17.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
2.5 | 14.9 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
2.5 | 27.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
2.5 | 5.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
2.5 | 7.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
2.5 | 4.9 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
2.5 | 4.9 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
2.5 | 2.5 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
2.5 | 2.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
2.5 | 7.4 | GO:0007525 | somatic muscle development(GO:0007525) |
2.5 | 4.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
2.5 | 7.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.4 | 7.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
2.4 | 19.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
2.4 | 4.8 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
2.4 | 9.7 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
2.4 | 4.8 | GO:1902065 | response to L-glutamate(GO:1902065) |
2.4 | 19.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
2.4 | 9.7 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
2.4 | 2.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
2.4 | 7.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
2.4 | 62.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
2.4 | 16.8 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
2.4 | 14.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
2.4 | 4.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
2.4 | 19.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
2.4 | 12.0 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
2.4 | 2.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.4 | 49.6 | GO:0014823 | response to activity(GO:0014823) |
2.4 | 7.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
2.4 | 11.8 | GO:0045332 | phospholipid translocation(GO:0045332) |
2.3 | 21.1 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
2.3 | 14.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
2.3 | 16.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
2.3 | 2.3 | GO:0061724 | lipophagy(GO:0061724) |
2.3 | 2.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
2.3 | 9.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
2.3 | 4.7 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
2.3 | 7.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
2.3 | 20.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
2.3 | 7.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
2.3 | 4.6 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.3 | 7.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.3 | 11.6 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
2.3 | 6.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
2.3 | 6.9 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
2.3 | 20.8 | GO:0070269 | pyroptosis(GO:0070269) |
2.3 | 9.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.3 | 9.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.3 | 9.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.3 | 16.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
2.3 | 9.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.3 | 6.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
2.3 | 4.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
2.3 | 13.7 | GO:0016266 | O-glycan processing(GO:0016266) |
2.3 | 9.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.3 | 4.5 | GO:0070828 | heterochromatin organization(GO:0070828) |
2.3 | 27.2 | GO:0051601 | exocyst localization(GO:0051601) |
2.3 | 4.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
2.3 | 9.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
2.3 | 15.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
2.3 | 11.3 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
2.3 | 2.3 | GO:0015817 | histidine transport(GO:0015817) |
2.2 | 2.2 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
2.2 | 13.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
2.2 | 9.0 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
2.2 | 35.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.2 | 9.0 | GO:0007296 | vitellogenesis(GO:0007296) |
2.2 | 13.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
2.2 | 4.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.2 | 8.9 | GO:0000212 | meiotic spindle organization(GO:0000212) |
2.2 | 6.7 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
2.2 | 6.7 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
2.2 | 6.7 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
2.2 | 2.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
2.2 | 2.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.2 | 8.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
2.2 | 2.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
2.2 | 13.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
2.2 | 6.6 | GO:0015671 | oxygen transport(GO:0015671) |
2.2 | 15.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
2.2 | 11.0 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
2.2 | 13.1 | GO:0006560 | proline metabolic process(GO:0006560) |
2.2 | 2.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
2.2 | 10.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
2.2 | 8.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.2 | 8.7 | GO:0051031 | tRNA transport(GO:0051031) |
2.2 | 4.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.2 | 15.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
2.2 | 4.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
2.2 | 4.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
2.2 | 13.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.2 | 8.7 | GO:0048496 | maintenance of organ identity(GO:0048496) |
2.2 | 6.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
2.2 | 4.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
2.2 | 49.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
2.2 | 15.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.2 | 6.5 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
2.1 | 8.6 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.1 | 6.4 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.1 | 10.7 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
2.1 | 8.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
2.1 | 6.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
2.1 | 2.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
2.1 | 19.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
2.1 | 21.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
2.1 | 2.1 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
2.1 | 2.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
2.1 | 12.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.1 | 10.5 | GO:1900246 | regulation of RIG-I signaling pathway(GO:0039535) positive regulation of RIG-I signaling pathway(GO:1900246) |
2.1 | 20.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
2.1 | 4.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
2.1 | 2.1 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
2.1 | 8.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
2.1 | 29.0 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
2.1 | 18.6 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
2.1 | 2.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.1 | 2.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
2.1 | 14.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
2.1 | 28.8 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
2.1 | 4.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.1 | 10.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
2.1 | 8.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
2.0 | 14.3 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
2.0 | 2.0 | GO:0006598 | polyamine catabolic process(GO:0006598) |
2.0 | 6.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
2.0 | 12.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
2.0 | 22.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
2.0 | 10.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
2.0 | 10.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
2.0 | 4.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
2.0 | 6.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
2.0 | 6.0 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
2.0 | 10.1 | GO:0009310 | amine catabolic process(GO:0009310) |
2.0 | 48.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
2.0 | 12.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
2.0 | 4.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
2.0 | 14.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
2.0 | 44.0 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
2.0 | 4.0 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
2.0 | 15.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
2.0 | 4.0 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
2.0 | 9.9 | GO:0051026 | chiasma assembly(GO:0051026) |
2.0 | 4.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
2.0 | 7.9 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
2.0 | 4.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
2.0 | 7.9 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
2.0 | 7.9 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
2.0 | 11.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
2.0 | 3.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
2.0 | 5.9 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
2.0 | 2.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
2.0 | 5.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.0 | 13.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
2.0 | 21.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
2.0 | 5.9 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
2.0 | 2.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
1.9 | 1.9 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.9 | 1.9 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
1.9 | 3.9 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.9 | 7.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.9 | 11.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.9 | 5.8 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
1.9 | 3.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
1.9 | 1.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.9 | 3.8 | GO:0040009 | regulation of growth rate(GO:0040009) |
1.9 | 24.9 | GO:0043486 | histone exchange(GO:0043486) |
1.9 | 3.8 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.9 | 36.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
1.9 | 3.8 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
1.9 | 3.8 | GO:0016264 | gap junction assembly(GO:0016264) |
1.9 | 7.6 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.9 | 5.7 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
1.9 | 13.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
1.9 | 5.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.9 | 5.7 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
1.9 | 1.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
1.9 | 5.7 | GO:0044351 | macropinocytosis(GO:0044351) |
1.9 | 11.4 | GO:0097421 | liver regeneration(GO:0097421) |
1.9 | 3.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.9 | 1.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
1.9 | 20.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.9 | 1.9 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
1.9 | 16.9 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.9 | 33.6 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
1.9 | 5.6 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.9 | 22.4 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.9 | 1.9 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.9 | 5.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.9 | 3.7 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.9 | 1.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
1.9 | 9.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.8 | 5.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.8 | 5.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.8 | 3.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.8 | 16.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.8 | 5.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
1.8 | 1.8 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
1.8 | 23.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.8 | 1.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
1.8 | 10.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.8 | 7.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.8 | 9.0 | GO:0031100 | organ regeneration(GO:0031100) |
1.8 | 5.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
1.8 | 39.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
1.8 | 32.3 | GO:0006301 | postreplication repair(GO:0006301) |
1.8 | 3.6 | GO:0071895 | odontoblast differentiation(GO:0071895) |
1.8 | 14.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.8 | 5.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
1.8 | 1.8 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
1.8 | 19.6 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
1.8 | 3.6 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.8 | 3.5 | GO:0070268 | cornification(GO:0070268) |
1.8 | 5.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.8 | 3.5 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.8 | 3.5 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
1.8 | 3.5 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.8 | 3.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
1.8 | 7.0 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.8 | 5.3 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.8 | 7.0 | GO:0001842 | neural fold formation(GO:0001842) |
1.8 | 5.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.7 | 29.6 | GO:0008089 | anterograde axonal transport(GO:0008089) |
1.7 | 10.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.7 | 1.7 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.7 | 6.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.7 | 5.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
1.7 | 6.9 | GO:0060242 | contact inhibition(GO:0060242) |
1.7 | 3.4 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.7 | 1.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.7 | 36.1 | GO:0006953 | acute-phase response(GO:0006953) |
1.7 | 1.7 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.7 | 1.7 | GO:1903332 | regulation of protein folding(GO:1903332) |
1.7 | 5.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.7 | 1.7 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
1.7 | 3.4 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
1.7 | 6.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
1.7 | 8.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.7 | 8.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
1.7 | 8.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.7 | 6.8 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
1.7 | 3.4 | GO:0072678 | T cell migration(GO:0072678) |
1.7 | 5.1 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.7 | 1.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.7 | 1.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
1.7 | 6.7 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.7 | 6.7 | GO:0080009 | mRNA methylation(GO:0080009) |
1.7 | 1.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.7 | 5.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
1.7 | 3.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.7 | 10.1 | GO:0046686 | response to cadmium ion(GO:0046686) |
1.7 | 10.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
1.7 | 5.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.7 | 3.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
1.7 | 1.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
1.7 | 16.7 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.7 | 5.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.7 | 6.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.7 | 18.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.7 | 1.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.7 | 3.3 | GO:1902075 | cellular response to salt(GO:1902075) |
1.6 | 19.8 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.6 | 1.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.6 | 4.9 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.6 | 3.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
1.6 | 1.6 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
1.6 | 9.8 | GO:0016559 | peroxisome fission(GO:0016559) |
1.6 | 6.6 | GO:0051451 | myoblast migration(GO:0051451) |
1.6 | 3.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.6 | 14.7 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
1.6 | 13.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.6 | 4.9 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.6 | 25.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
1.6 | 6.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.6 | 4.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.6 | 4.8 | GO:0006573 | valine metabolic process(GO:0006573) |
1.6 | 1.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
1.6 | 6.4 | GO:0036314 | response to sterol(GO:0036314) |
1.6 | 3.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
1.6 | 3.2 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.6 | 3.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.6 | 3.2 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.6 | 8.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
1.6 | 17.6 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
1.6 | 63.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.6 | 12.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.6 | 4.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.6 | 1.6 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
1.6 | 3.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.6 | 20.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.6 | 6.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.6 | 4.7 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.5 | 3.1 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.5 | 9.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
1.5 | 4.6 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.5 | 6.2 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
1.5 | 4.6 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
1.5 | 7.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.5 | 6.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.5 | 1.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.5 | 1.5 | GO:0097531 | mast cell migration(GO:0097531) |
1.5 | 1.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.5 | 1.5 | GO:0090148 | membrane fission(GO:0090148) |
1.5 | 3.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.5 | 10.6 | GO:0030575 | nuclear body organization(GO:0030575) |
1.5 | 4.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
1.5 | 3.0 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
1.5 | 4.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.5 | 6.0 | GO:0090399 | replicative senescence(GO:0090399) |
1.5 | 3.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
1.5 | 4.5 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
1.5 | 1.5 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
1.5 | 7.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.5 | 7.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.5 | 3.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.5 | 1.5 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
1.5 | 6.0 | GO:0060613 | fat pad development(GO:0060613) |
1.5 | 4.5 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.5 | 3.0 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
1.5 | 3.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.5 | 13.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
1.5 | 4.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.5 | 5.9 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
1.5 | 13.4 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
1.5 | 19.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
1.5 | 1.5 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
1.5 | 3.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.5 | 4.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.5 | 2.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.5 | 2.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
1.5 | 4.4 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.5 | 10.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.5 | 11.6 | GO:0051382 | kinetochore assembly(GO:0051382) |
1.5 | 17.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
1.5 | 18.9 | GO:1902686 | positive regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902110) mitochondrial outer membrane permeabilization involved in programmed cell death(GO:1902686) |
1.5 | 16.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.5 | 2.9 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
1.4 | 1.4 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
1.4 | 2.9 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.4 | 1.4 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
1.4 | 2.9 | GO:0007000 | nucleolus organization(GO:0007000) |
1.4 | 1.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.4 | 2.9 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.4 | 11.5 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
1.4 | 4.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.4 | 1.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.4 | 4.3 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
1.4 | 4.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.4 | 2.8 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
1.4 | 2.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.4 | 9.9 | GO:0009650 | UV protection(GO:0009650) |
1.4 | 1.4 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
1.4 | 5.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.4 | 4.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
1.4 | 12.7 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.4 | 9.9 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.4 | 9.9 | GO:0015893 | drug transport(GO:0015893) |
1.4 | 4.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.4 | 14.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.4 | 5.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.4 | 4.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.4 | 1.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
1.4 | 8.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
1.4 | 2.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
1.4 | 1.4 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
1.4 | 25.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.4 | 7.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.4 | 7.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.4 | 2.8 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
1.4 | 7.0 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
1.4 | 5.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.4 | 2.8 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.4 | 1.4 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
1.4 | 1.4 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.4 | 11.1 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
1.4 | 1.4 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.4 | 5.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.4 | 2.8 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
1.4 | 15.1 | GO:0045116 | protein neddylation(GO:0045116) |
1.4 | 9.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.4 | 15.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.4 | 9.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
1.4 | 1.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.4 | 4.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
1.4 | 2.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.4 | 4.1 | GO:0019086 | late viral transcription(GO:0019086) |
1.4 | 4.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.4 | 9.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
1.4 | 8.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.4 | 6.8 | GO:0046836 | glycolipid transport(GO:0046836) |
1.3 | 22.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.3 | 1.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.3 | 16.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.3 | 2.7 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.3 | 2.7 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.3 | 1.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.3 | 6.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.3 | 6.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.3 | 4.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
1.3 | 5.3 | GO:0042730 | fibrinolysis(GO:0042730) |
1.3 | 1.3 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.3 | 8.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.3 | 5.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
1.3 | 6.6 | GO:0051013 | microtubule severing(GO:0051013) |
1.3 | 9.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.3 | 7.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.3 | 2.6 | GO:0044774 | mitotic DNA integrity checkpoint(GO:0044774) |
1.3 | 1.3 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
1.3 | 6.6 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
1.3 | 1.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.3 | 5.3 | GO:0070071 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.3 | 10.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.3 | 1.3 | GO:0031498 | chromatin disassembly(GO:0031498) |
1.3 | 1.3 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
1.3 | 6.6 | GO:0009404 | toxin metabolic process(GO:0009404) |
1.3 | 2.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
1.3 | 14.5 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
1.3 | 3.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
1.3 | 5.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.3 | 9.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
1.3 | 1.3 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
1.3 | 2.6 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
1.3 | 2.6 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
1.3 | 3.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
1.3 | 2.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.3 | 3.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.3 | 3.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.3 | 14.3 | GO:0048535 | lymph node development(GO:0048535) |
1.3 | 2.6 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
1.3 | 3.9 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.3 | 2.6 | GO:0016556 | mRNA modification(GO:0016556) |
1.3 | 1.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.3 | 1.3 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
1.3 | 3.9 | GO:0033227 | dsRNA transport(GO:0033227) |
1.3 | 2.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
1.3 | 2.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.3 | 20.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.3 | 3.8 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
1.3 | 1.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
1.3 | 20.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.3 | 2.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
1.3 | 3.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
1.3 | 20.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.3 | 2.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.3 | 3.8 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.3 | 21.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.3 | 5.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
1.3 | 3.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.3 | 2.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.3 | 2.5 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
1.3 | 3.8 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
1.3 | 2.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.3 | 2.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.3 | 2.5 | GO:1901727 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
1.3 | 10.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
1.2 | 6.2 | GO:0015825 | L-serine transport(GO:0015825) |
1.2 | 8.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.2 | 2.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
1.2 | 2.5 | GO:0002215 | defense response to nematode(GO:0002215) |
1.2 | 11.2 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
1.2 | 9.9 | GO:0051452 | intracellular pH reduction(GO:0051452) |
1.2 | 3.7 | GO:0018343 | protein farnesylation(GO:0018343) |
1.2 | 9.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
1.2 | 7.4 | GO:0046456 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
1.2 | 2.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
1.2 | 6.2 | GO:0046415 | urate metabolic process(GO:0046415) |
1.2 | 1.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.2 | 18.5 | GO:0071539 | protein localization to centrosome(GO:0071539) |
1.2 | 1.2 | GO:0019042 | viral latency(GO:0019042) |
1.2 | 9.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.2 | 7.3 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
1.2 | 8.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
1.2 | 12.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
1.2 | 1.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.2 | 2.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.2 | 6.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
1.2 | 9.7 | GO:0009301 | snRNA transcription(GO:0009301) |
1.2 | 2.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
1.2 | 1.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.2 | 6.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
1.2 | 22.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
1.2 | 6.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.2 | 6.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.2 | 1.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
1.2 | 1.2 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
1.2 | 8.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.2 | 1.2 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
1.2 | 3.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.2 | 1.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.2 | 23.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.2 | 1.2 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
1.2 | 9.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
1.2 | 10.7 | GO:0006826 | iron ion transport(GO:0006826) |
1.2 | 3.6 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
1.2 | 8.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
1.2 | 2.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
1.2 | 7.1 | GO:0001771 | immunological synapse formation(GO:0001771) |
1.2 | 1.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.2 | 12.9 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.2 | 4.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.2 | 1.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.2 | 3.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.2 | 1.2 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
1.2 | 1.2 | GO:0035510 | DNA dealkylation(GO:0035510) |
1.2 | 1.2 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
1.2 | 2.3 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of epidermis development(GO:0045683) |
1.2 | 7.0 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
1.2 | 3.5 | GO:1904406 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
1.2 | 9.3 | GO:0046051 | UTP metabolic process(GO:0046051) |
1.2 | 1.2 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
1.2 | 7.0 | GO:0007343 | egg activation(GO:0007343) |
1.2 | 5.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.2 | 2.3 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.2 | 3.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.2 | 12.7 | GO:0008272 | sulfate transport(GO:0008272) |
1.2 | 3.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.2 | 3.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.2 | 11.6 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.2 | 6.9 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.2 | 3.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.2 | 5.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
1.1 | 1.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.1 | 3.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.1 | 1.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
1.1 | 4.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.1 | 19.4 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
1.1 | 5.7 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
1.1 | 3.4 | GO:0097240 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.1 | 3.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.1 | 4.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.1 | 2.2 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
1.1 | 3.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.1 | 29.2 | GO:0031929 | TOR signaling(GO:0031929) |
1.1 | 13.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
1.1 | 2.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
1.1 | 1.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
1.1 | 1.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
1.1 | 8.9 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
1.1 | 22.3 | GO:0016180 | snRNA processing(GO:0016180) |
1.1 | 3.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.1 | 5.6 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
1.1 | 2.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
1.1 | 1.1 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.1 | 36.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
1.1 | 6.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.1 | 3.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.1 | 1.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.1 | 1.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
1.1 | 1.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.1 | 1.1 | GO:0043366 | beta selection(GO:0043366) |
1.1 | 14.2 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.1 | 4.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.1 | 11.9 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
1.1 | 1.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
1.1 | 8.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.1 | 6.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.1 | 3.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.1 | 2.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
1.1 | 2.1 | GO:0071514 | genetic imprinting(GO:0071514) |
1.1 | 3.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.1 | 2.1 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
1.1 | 11.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
1.1 | 2.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.1 | 5.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.1 | 2.1 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
1.1 | 8.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.1 | 4.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.1 | 5.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.1 | 2.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.1 | 2.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
1.1 | 6.3 | GO:0031167 | rRNA methylation(GO:0031167) |
1.1 | 8.4 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
1.1 | 25.3 | GO:0030168 | platelet activation(GO:0030168) |
1.1 | 1.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
1.1 | 18.9 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.0 | 2.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.0 | 7.3 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.0 | 3.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.0 | 1.0 | GO:0046078 | dUMP metabolic process(GO:0046078) |
1.0 | 4.2 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
1.0 | 2.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
1.0 | 1.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.0 | 5.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
1.0 | 16.6 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
1.0 | 2.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.0 | 1.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
1.0 | 7.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.0 | 1.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.0 | 1.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
1.0 | 1.0 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
1.0 | 9.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
1.0 | 3.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
1.0 | 1.0 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
1.0 | 3.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.0 | 3.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
1.0 | 2.0 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
1.0 | 4.1 | GO:0015871 | choline transport(GO:0015871) |
1.0 | 2.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.0 | 34.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
1.0 | 3.0 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
1.0 | 11.1 | GO:0060674 | placenta blood vessel development(GO:0060674) |
1.0 | 2.0 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
1.0 | 3.0 | GO:0052312 | modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
1.0 | 5.0 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
1.0 | 10.1 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
1.0 | 1.0 | GO:0007619 | courtship behavior(GO:0007619) |
1.0 | 3.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.0 | 3.0 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
1.0 | 7.0 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
1.0 | 1.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
1.0 | 4.0 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
1.0 | 1.0 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
1.0 | 3.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.0 | 34.9 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
1.0 | 4.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.0 | 1.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
1.0 | 8.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.0 | 17.9 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
1.0 | 1.0 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
1.0 | 7.0 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
1.0 | 1.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.0 | 2.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.0 | 26.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.0 | 3.0 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
1.0 | 7.9 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
1.0 | 3.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
1.0 | 5.9 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
1.0 | 3.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
1.0 | 3.9 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
1.0 | 2.0 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.0 | 1.0 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
1.0 | 1.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.0 | 4.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.0 | 1.0 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.0 | 3.9 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.0 | 1.9 | GO:0001302 | replicative cell aging(GO:0001302) |
1.0 | 1.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.0 | 3.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.0 | 1.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
1.0 | 2.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.0 | 6.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.0 | 2.9 | GO:0001774 | microglial cell activation(GO:0001774) |
0.9 | 3.8 | GO:0000012 | single strand break repair(GO:0000012) |
0.9 | 0.9 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.9 | 24.6 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.9 | 42.5 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.9 | 1.9 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.9 | 0.9 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.9 | 2.8 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.9 | 2.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.9 | 0.9 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.9 | 1.9 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.9 | 2.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.9 | 2.8 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.9 | 2.8 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.9 | 5.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.9 | 4.6 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.9 | 8.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.9 | 0.9 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.9 | 5.6 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.9 | 1.8 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.9 | 2.8 | GO:0015888 | thiamine transport(GO:0015888) |
0.9 | 13.8 | GO:0007569 | cell aging(GO:0007569) |
0.9 | 23.9 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.9 | 3.7 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.9 | 7.4 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.9 | 0.9 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.9 | 3.7 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.9 | 0.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.9 | 4.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.9 | 24.5 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.9 | 0.9 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.9 | 1.8 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.9 | 6.3 | GO:0007141 | male meiosis I(GO:0007141) |
0.9 | 1.8 | GO:0060023 | soft palate development(GO:0060023) |
0.9 | 0.9 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.9 | 3.6 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) |
0.9 | 17.0 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.9 | 18.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.9 | 7.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.9 | 19.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.9 | 4.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.9 | 3.5 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.9 | 0.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.9 | 6.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.9 | 6.2 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.9 | 6.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.9 | 2.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.9 | 4.4 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 0.9 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) negative regulation of neutrophil apoptotic process(GO:0033030) |
0.9 | 0.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.9 | 2.6 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.9 | 9.6 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.9 | 14.9 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.9 | 0.9 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.9 | 1.7 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.9 | 1.7 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.9 | 118.2 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.9 | 0.9 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.9 | 2.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.9 | 0.9 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.9 | 2.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.9 | 0.9 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.9 | 2.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.9 | 2.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.9 | 0.9 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.9 | 6.9 | GO:0043248 | proteasome assembly(GO:0043248) |
0.9 | 0.9 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.9 | 0.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.9 | 14.6 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.9 | 0.9 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.9 | 2.6 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.9 | 1.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.9 | 1.7 | GO:1902751 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.9 | 5.1 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.8 | 3.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.8 | 4.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.8 | 0.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.8 | 0.8 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.8 | 14.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.8 | 0.8 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.8 | 1.7 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.8 | 0.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.8 | 4.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.8 | 1.7 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.8 | 0.8 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
0.8 | 5.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.8 | 0.8 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.8 | 2.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.8 | 0.8 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.8 | 0.8 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.8 | 3.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.8 | 9.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.8 | 13.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.8 | 3.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.8 | 1.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.8 | 0.8 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.8 | 6.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.8 | 1.6 | GO:0033762 | response to glucagon(GO:0033762) |
0.8 | 1.6 | GO:2000665 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.8 | 0.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.8 | 21.6 | GO:0006310 | DNA recombination(GO:0006310) |
0.8 | 1.6 | GO:0043144 | snoRNA processing(GO:0043144) |
0.8 | 2.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.8 | 0.8 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.8 | 11.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.8 | 3.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.8 | 4.7 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.8 | 3.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.8 | 3.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.8 | 4.7 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.8 | 1.6 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.8 | 0.8 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
0.8 | 4.7 | GO:0030261 | chromosome condensation(GO:0030261) |
0.8 | 6.2 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.8 | 3.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.8 | 3.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.8 | 1.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.8 | 6.9 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.8 | 7.7 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
0.8 | 6.1 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.8 | 3.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.8 | 2.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.8 | 5.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.8 | 2.3 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.8 | 5.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.8 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 2.3 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.8 | 4.5 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.8 | 0.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.7 | 12.0 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.7 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 3.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.7 | 14.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.7 | 1.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 2.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.7 | 4.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.7 | 5.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.7 | 0.7 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.7 | 3.6 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.7 | 4.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.7 | 1.4 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.7 | 0.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.7 | 3.6 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.7 | 1.4 | GO:0002825 | regulation of T-helper 1 type immune response(GO:0002825) |
0.7 | 7.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.7 | 2.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 5.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.7 | 2.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.7 | 1.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.7 | 1.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 1.4 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.7 | 2.9 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.7 | 0.7 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.7 | 2.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.7 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.7 | 0.7 | GO:0050779 | RNA destabilization(GO:0050779) |
0.7 | 3.5 | GO:0006415 | translational termination(GO:0006415) |
0.7 | 2.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.7 | 0.7 | GO:0060157 | urinary bladder development(GO:0060157) |
0.7 | 6.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.7 | 4.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.7 | 0.7 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.7 | 2.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 0.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.7 | 2.8 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.7 | 2.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
0.7 | 4.9 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.7 | 1.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.7 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.7 | 0.7 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.7 | 0.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.7 | 2.1 | GO:0043084 | penile erection(GO:0043084) |
0.7 | 1.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.7 | 23.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.7 | 9.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.7 | 0.7 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.7 | 2.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.7 | 0.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.7 | 9.5 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.7 | 26.5 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.7 | 2.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.7 | 1.4 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.7 | 14.2 | GO:1903825 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.7 | 1.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.7 | 6.0 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.7 | 13.3 | GO:0019079 | viral genome replication(GO:0019079) |
0.7 | 0.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.7 | 4.0 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.7 | 4.6 | GO:0016926 | protein desumoylation(GO:0016926) |
0.7 | 1.3 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 2.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 0.6 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.6 | 4.5 | GO:0046466 | glycolipid catabolic process(GO:0019377) membrane lipid catabolic process(GO:0046466) |
0.6 | 3.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.6 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.6 | 4.5 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
0.6 | 0.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.6 | 3.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.6 | 0.6 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.6 | 2.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.6 | 1.9 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 0.6 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.6 | 5.7 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.6 | 1.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.6 | 0.6 | GO:0051900 | mitochondrial depolarization(GO:0051882) regulation of mitochondrial depolarization(GO:0051900) |
0.6 | 0.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.6 | 7.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 1.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 | 1.3 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.6 | 6.2 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.6 | 2.5 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.6 | 0.6 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) positive regulation of phospholipase A2 activity(GO:0032430) |
0.6 | 3.1 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.6 | 0.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.6 | 2.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 0.6 | GO:0033058 | directional locomotion(GO:0033058) |
0.6 | 0.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.6 | 0.6 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.6 | 0.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.6 | 0.6 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.6 | 3.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.6 | 4.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.6 | 13.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.6 | 3.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.6 | 1.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 8.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.6 | 1.8 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.6 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 4.8 | GO:0048144 | fibroblast proliferation(GO:0048144) |
0.6 | 4.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.6 | 17.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.6 | 8.8 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.6 | 3.5 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.6 | 1.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.6 | 0.6 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.6 | 2.3 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.6 | 2.9 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.6 | 1.2 | GO:0050955 | thermoception(GO:0050955) |
0.6 | 2.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.6 | 1.7 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.6 | 0.6 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.6 | 6.2 | GO:0051028 | mRNA transport(GO:0051028) |
0.6 | 5.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.6 | 1.1 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.6 | 0.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.6 | 6.7 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.6 | 4.5 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.6 | 2.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.6 | 112.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.6 | 1.1 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.6 | 0.6 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.6 | 1.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.6 | 19.3 | GO:0051168 | nuclear export(GO:0051168) |
0.6 | 2.2 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.6 | 3.9 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.5 | 1.1 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.5 | 4.9 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.5 | 17.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.5 | 0.5 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.5 | 56.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.5 | 2.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.5 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.5 | 18.0 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
0.5 | 1.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 0.5 | GO:0034340 | response to type I interferon(GO:0034340) |
0.5 | 3.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.5 | 2.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 0.5 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.5 | 16.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.5 | 3.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.5 | 1.1 | GO:0060968 | regulation of gene silencing(GO:0060968) |
0.5 | 1.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.5 | 3.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.5 | 1.0 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.5 | 0.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.5 | 7.3 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.5 | 3.1 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.5 | 1.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.5 | 0.5 | GO:0002883 | regulation of hypersensitivity(GO:0002883) |
0.5 | 0.5 | GO:0044242 | cellular lipid catabolic process(GO:0044242) |
0.5 | 2.0 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.5 | 8.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.5 | 1.0 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
0.5 | 1.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.5 | 1.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.5 | 1.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.5 | 3.0 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.5 | 1.5 | GO:0046605 | regulation of centrosome cycle(GO:0046605) |
0.5 | 0.5 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.5 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.5 | 6.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.5 | 1.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.5 | 2.0 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.5 | 3.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.5 | 2.9 | GO:0000338 | protein deneddylation(GO:0000338) |
0.5 | 1.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.5 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.5 | 7.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.5 | 1.0 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.5 | 0.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.5 | 1.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.5 | 2.9 | GO:0055076 | transition metal ion homeostasis(GO:0055076) |
0.5 | 6.2 | GO:0019835 | cytolysis(GO:0019835) |
0.5 | 1.4 | GO:0036233 | glycine import(GO:0036233) |
0.5 | 2.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 1.4 | GO:0051775 | response to redox state(GO:0051775) |
0.5 | 6.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.5 | 2.3 | GO:0007595 | lactation(GO:0007595) |
0.5 | 0.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.5 | 0.5 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.5 | 0.9 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.5 | 1.4 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.5 | 4.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.5 | 0.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 0.9 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.5 | 4.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.5 | 2.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.4 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.4 | 1.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.4 | 3.1 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.4 | 0.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 0.9 | GO:0042454 | ribonucleoside catabolic process(GO:0042454) |
0.4 | 3.1 | GO:0032438 | melanosome organization(GO:0032438) |
0.4 | 0.4 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.4 | 0.9 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 1.7 | GO:0002507 | tolerance induction(GO:0002507) |
0.4 | 1.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 19.8 | GO:0030217 | T cell differentiation(GO:0030217) |
0.4 | 13.3 | GO:0006457 | protein folding(GO:0006457) |
0.4 | 3.0 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.4 | 0.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 12.1 | GO:0006956 | complement activation(GO:0006956) |
0.4 | 10.4 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.4 | 5.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.4 | 1.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.4 | 0.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.4 | 1.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.4 | 20.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.4 | 0.4 | GO:0015810 | aspartate transport(GO:0015810) |
0.4 | 2.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 12.1 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.4 | 0.8 | GO:0001757 | somite specification(GO:0001757) |
0.4 | 0.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 4.8 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.4 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 0.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 8.6 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.4 | 0.8 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.4 | 1.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 1.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.4 | 0.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.4 | 1.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.4 | 1.1 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.4 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.4 | 1.5 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.4 | 0.4 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.4 | 1.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 3.3 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.4 | 1.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.4 | 0.4 | GO:0044409 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.4 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 1.5 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.4 | 1.5 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.4 | 4.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.4 | 0.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.4 | 0.4 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.4 | 0.4 | GO:0006304 | DNA modification(GO:0006304) |
0.4 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 0.4 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.4 | 3.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.4 | 0.7 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.4 | 1.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 0.7 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.4 | 1.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 0.7 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 1.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.3 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.3 | 0.7 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 0.3 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.3 | 6.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.3 | 6.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 1.0 | GO:0001510 | RNA methylation(GO:0001510) |
0.3 | 2.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 3.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.3 | 5.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 0.3 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.3 | 0.3 | GO:0090594 | wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
0.3 | 0.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.3 | 4.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.3 | 0.3 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.3 | 0.3 | GO:0071221 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.3 | 3.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 1.3 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.3 | 0.7 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.3 | 10.0 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) |
0.3 | 3.5 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.3 | 1.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 0.3 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.3 | 0.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 | 5.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.3 | 2.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.3 | 0.3 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 1.2 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 23.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.3 | 0.9 | GO:0070266 | necroptotic process(GO:0070266) |
0.3 | 2.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 0.6 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.3 | 2.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.3 | 0.3 | GO:0046688 | response to copper ion(GO:0046688) |
0.3 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 0.9 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.3 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 1.7 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.3 | 0.3 | GO:0007320 | insemination(GO:0007320) |
0.3 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.3 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.3 | 0.6 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.3 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 1.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.3 | 1.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.3 | 0.5 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 2.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 0.5 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 0.8 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.3 | 0.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.3 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.3 | 0.3 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.3 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.3 | 0.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 1.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.3 | 2.3 | GO:0071467 | cellular response to pH(GO:0071467) |
0.2 | 2.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 2.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 5.9 | GO:0007596 | blood coagulation(GO:0007596) |
0.2 | 0.5 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.5 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.2 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 5.0 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.2 | 0.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.2 | 0.2 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.2 | 0.2 | GO:1901616 | organic hydroxy compound catabolic process(GO:1901616) |
0.2 | 0.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 2.0 | GO:1901998 | toxin transport(GO:1901998) |
0.2 | 0.7 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 1.3 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 1.5 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.2 | 0.2 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.2 | 1.3 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.2 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.2 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.2 | 0.9 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 3.2 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.2 | 1.7 | GO:0009451 | RNA modification(GO:0009451) |
0.2 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 4.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.2 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 0.2 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 0.2 | GO:1903902 | positive regulation of viral life cycle(GO:1903902) |
0.2 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.2 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.8 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 9.2 | GO:0071241 | cellular response to inorganic substance(GO:0071241) |
0.2 | 0.2 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.2 | 1.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.6 | GO:0045851 | pH reduction(GO:0045851) |
0.2 | 0.4 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 1.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 0.2 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.2 | 7.8 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.2 | 1.1 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.2 | 0.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.4 | GO:0044838 | cell quiescence(GO:0044838) |
0.2 | 0.2 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.2 | 0.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 1.8 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.4 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.5 | GO:0050892 | intestinal absorption(GO:0050892) |
0.2 | 0.2 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.2 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.2 | 0.2 | GO:0034032 | coenzyme A metabolic process(GO:0015936) nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.2 | 0.2 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.2 | 0.2 | GO:0001909 | leukocyte mediated cytotoxicity(GO:0001909) |
0.2 | 13.4 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.2 | 1.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 36.0 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.2 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 3.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 1.7 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.2 | 7.2 | GO:0045087 | innate immune response(GO:0045087) |
0.2 | 0.2 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.2 | 1.4 | GO:0007602 | phototransduction(GO:0007602) |
0.2 | 1.7 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.2 | 0.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 1.8 | GO:0006323 | DNA packaging(GO:0006323) |
0.1 | 1.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 0.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.1 | 1.0 | GO:0033363 | secretory granule organization(GO:0033363) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 1.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 2.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.5 | GO:0048741 | myotube cell development(GO:0014904) skeletal muscle fiber development(GO:0048741) |
0.1 | 1.9 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.1 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.5 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.1 | 0.8 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 0.4 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.6 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.7 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.5 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.1 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.1 | 0.1 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.1 | 0.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.2 | GO:0043620 | regulation of DNA-templated transcription in response to stress(GO:0043620) |
0.1 | 3.8 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.1 | 0.1 | GO:0002889 | regulation of B cell mediated immunity(GO:0002712) regulation of immunoglobulin mediated immune response(GO:0002889) |
0.1 | 0.1 | GO:0032329 | serine transport(GO:0032329) |
0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0048525 | negative regulation of viral process(GO:0048525) |
0.1 | 0.1 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.5 | GO:0002792 | negative regulation of peptide secretion(GO:0002792) |
0.1 | 0.1 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
0.1 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.1 | 0.4 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 1.1 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.4 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.1 | 4.6 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 1.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.6 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.0 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.0 | 0.2 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.0 | GO:0060847 | endothelial cell fate commitment(GO:0060839) endothelial cell fate specification(GO:0060847) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.0 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.0 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.0 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.0 | 2.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.0 | GO:0015740 | tricarboxylic acid transport(GO:0006842) C4-dicarboxylate transport(GO:0015740) succinate transport(GO:0015744) citrate transport(GO:0015746) |
0.0 | 20.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.0 | 64.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
13.3 | 66.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
9.5 | 28.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
7.3 | 36.7 | GO:0033093 | Weibel-Palade body(GO:0033093) |
7.1 | 35.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
7.0 | 27.9 | GO:0072487 | MSL complex(GO:0072487) |
7.0 | 20.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
6.8 | 20.5 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
6.7 | 33.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
6.2 | 31.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
6.2 | 18.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
5.9 | 47.5 | GO:0045179 | apical cortex(GO:0045179) |
5.8 | 5.8 | GO:0097450 | astrocyte end-foot(GO:0097450) |
5.8 | 23.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
5.3 | 31.8 | GO:0001739 | sex chromatin(GO:0001739) |
5.3 | 21.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
5.1 | 25.6 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
5.0 | 15.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
5.0 | 25.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
5.0 | 10.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
4.7 | 14.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
4.7 | 14.2 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
4.7 | 9.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
4.6 | 18.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
4.6 | 64.3 | GO:0031528 | microvillus membrane(GO:0031528) |
4.5 | 13.6 | GO:0031523 | Myb complex(GO:0031523) |
4.4 | 26.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
4.4 | 13.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
4.4 | 22.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
4.3 | 17.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
4.3 | 17.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
4.3 | 21.4 | GO:0005638 | lamin filament(GO:0005638) |
4.2 | 29.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
4.2 | 8.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
4.1 | 4.1 | GO:0030120 | vesicle coat(GO:0030120) |
4.0 | 4.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
4.0 | 4.0 | GO:0031512 | motile primary cilium(GO:0031512) |
3.8 | 57.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
3.8 | 15.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
3.8 | 3.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
3.8 | 15.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
3.7 | 11.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
3.7 | 18.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
3.7 | 37.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
3.7 | 25.7 | GO:0035102 | PRC1 complex(GO:0035102) |
3.6 | 10.7 | GO:0097443 | sorting endosome(GO:0097443) |
3.6 | 10.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
3.5 | 17.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
3.5 | 31.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
3.5 | 17.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
3.5 | 24.3 | GO:0070688 | MLL5-L complex(GO:0070688) |
3.4 | 10.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
3.4 | 13.6 | GO:0005642 | annulate lamellae(GO:0005642) |
3.4 | 10.2 | GO:1990462 | omegasome(GO:1990462) |
3.4 | 105.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
3.3 | 3.3 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
3.3 | 13.2 | GO:0071203 | WASH complex(GO:0071203) |
3.3 | 9.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
3.2 | 6.5 | GO:0008091 | spectrin(GO:0008091) |
3.2 | 32.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
3.2 | 9.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
3.2 | 6.4 | GO:0005579 | membrane attack complex(GO:0005579) |
3.2 | 6.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
3.1 | 18.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
3.1 | 18.6 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
3.0 | 9.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
3.0 | 3.0 | GO:0000346 | transcription export complex(GO:0000346) |
2.9 | 8.8 | GO:0005833 | hemoglobin complex(GO:0005833) |
2.9 | 11.6 | GO:0071565 | nBAF complex(GO:0071565) |
2.9 | 11.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.8 | 14.1 | GO:0031983 | vesicle lumen(GO:0031983) |
2.8 | 14.0 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
2.8 | 2.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
2.8 | 2.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.8 | 41.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.8 | 126.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
2.7 | 19.2 | GO:0031931 | TORC1 complex(GO:0031931) |
2.7 | 2.7 | GO:1990423 | RZZ complex(GO:1990423) |
2.7 | 2.7 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
2.7 | 16.4 | GO:0097470 | ribbon synapse(GO:0097470) |
2.7 | 242.4 | GO:0072562 | blood microparticle(GO:0072562) |
2.7 | 19.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
2.7 | 10.8 | GO:1990130 | Iml1 complex(GO:1990130) |
2.7 | 10.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
2.7 | 13.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.7 | 21.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
2.6 | 15.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.6 | 107.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
2.6 | 18.3 | GO:0043219 | lateral loop(GO:0043219) |
2.5 | 7.6 | GO:1990923 | PET complex(GO:1990923) |
2.5 | 10.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
2.5 | 10.0 | GO:1990246 | uniplex complex(GO:1990246) |
2.5 | 37.3 | GO:0000145 | exocyst(GO:0000145) |
2.4 | 14.5 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
2.4 | 2.4 | GO:0022624 | proteasome accessory complex(GO:0022624) |
2.4 | 14.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
2.4 | 9.6 | GO:0042825 | TAP complex(GO:0042825) |
2.4 | 7.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
2.4 | 4.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.4 | 16.5 | GO:0043203 | axon hillock(GO:0043203) |
2.3 | 9.3 | GO:0045293 | mRNA editing complex(GO:0045293) |
2.3 | 18.3 | GO:0030056 | hemidesmosome(GO:0030056) |
2.3 | 6.9 | GO:0070552 | BRISC complex(GO:0070552) |
2.3 | 34.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
2.3 | 6.8 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
2.2 | 8.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.2 | 22.1 | GO:0034709 | methylosome(GO:0034709) |
2.2 | 24.2 | GO:0032039 | integrator complex(GO:0032039) |
2.2 | 15.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.2 | 6.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
2.2 | 2.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.2 | 8.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
2.2 | 125.5 | GO:0005811 | lipid particle(GO:0005811) |
2.2 | 21.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
2.1 | 31.9 | GO:0043034 | costamere(GO:0043034) |
2.1 | 12.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.1 | 73.3 | GO:0016592 | mediator complex(GO:0016592) |
2.1 | 14.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
2.1 | 14.4 | GO:0001650 | fibrillar center(GO:0001650) |
2.0 | 4.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.0 | 18.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
2.0 | 6.1 | GO:0033269 | internode region of axon(GO:0033269) |
2.0 | 10.2 | GO:0071439 | clathrin complex(GO:0071439) |
2.0 | 10.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
2.0 | 210.6 | GO:0005903 | brush border(GO:0005903) |
2.0 | 269.0 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
2.0 | 10.0 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.0 | 6.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
2.0 | 5.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
2.0 | 11.8 | GO:0010008 | endosome membrane(GO:0010008) |
2.0 | 3.9 | GO:0033263 | CORVET complex(GO:0033263) |
2.0 | 9.8 | GO:0097422 | tubular endosome(GO:0097422) |
1.9 | 5.8 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.9 | 5.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
1.9 | 1.9 | GO:0044327 | dendritic spine head(GO:0044327) |
1.9 | 15.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.9 | 113.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.9 | 7.6 | GO:0005767 | secondary lysosome(GO:0005767) |
1.9 | 7.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.9 | 5.7 | GO:0031417 | NatC complex(GO:0031417) |
1.9 | 3.7 | GO:0005914 | spot adherens junction(GO:0005914) |
1.9 | 22.2 | GO:0045120 | pronucleus(GO:0045120) |
1.8 | 9.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.8 | 12.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.8 | 34.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.8 | 9.1 | GO:0005796 | Golgi lumen(GO:0005796) |
1.8 | 52.5 | GO:0005776 | autophagosome(GO:0005776) |
1.8 | 14.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.8 | 19.9 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
1.8 | 5.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.8 | 17.9 | GO:0005682 | U5 snRNP(GO:0005682) |
1.8 | 19.6 | GO:0010369 | chromocenter(GO:0010369) |
1.8 | 103.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.8 | 5.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.8 | 14.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.8 | 3.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.8 | 10.6 | GO:0042587 | glycogen granule(GO:0042587) |
1.8 | 99.1 | GO:0016605 | PML body(GO:0016605) |
1.8 | 5.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.8 | 1.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.8 | 5.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.8 | 110.8 | GO:0016363 | nuclear matrix(GO:0016363) |
1.8 | 5.3 | GO:0097413 | Lewy body(GO:0097413) |
1.8 | 31.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.7 | 6.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.7 | 12.0 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
1.7 | 39.4 | GO:0001772 | immunological synapse(GO:0001772) |
1.7 | 5.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.7 | 42.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.7 | 5.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
1.7 | 5.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.7 | 5.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.7 | 19.9 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
1.6 | 11.5 | GO:0046930 | pore complex(GO:0046930) |
1.6 | 32.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.6 | 1.6 | GO:0061574 | ASAP complex(GO:0061574) |
1.6 | 8.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
1.6 | 14.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.6 | 22.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
1.6 | 4.8 | GO:0043293 | apoptosome(GO:0043293) |
1.6 | 8.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.6 | 4.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.6 | 3.2 | GO:0016939 | kinesin II complex(GO:0016939) |
1.6 | 25.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.6 | 99.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.6 | 4.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.6 | 4.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
1.6 | 39.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.6 | 18.6 | GO:0031430 | M band(GO:0031430) |
1.6 | 10.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.5 | 26.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.5 | 21.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.5 | 4.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.5 | 4.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.5 | 3.0 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.5 | 19.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.5 | 7.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
1.5 | 4.4 | GO:0044194 | cytolytic granule(GO:0044194) |
1.5 | 4.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.5 | 61.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
1.5 | 4.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.5 | 27.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.5 | 4.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.5 | 1.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
1.5 | 7.3 | GO:0032009 | early phagosome(GO:0032009) |
1.4 | 20.3 | GO:0031941 | filamentous actin(GO:0031941) |
1.4 | 14.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.4 | 11.6 | GO:0005657 | replication fork(GO:0005657) |
1.4 | 1.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
1.4 | 18.8 | GO:0001891 | phagocytic cup(GO:0001891) |
1.4 | 12.9 | GO:0005869 | dynactin complex(GO:0005869) |
1.4 | 4.3 | GO:0000805 | X chromosome(GO:0000805) |
1.4 | 18.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.4 | 57.9 | GO:0042641 | actomyosin(GO:0042641) |
1.4 | 5.6 | GO:0035339 | SPOTS complex(GO:0035339) |
1.4 | 2.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.4 | 50.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.4 | 8.4 | GO:0031415 | NatA complex(GO:0031415) |
1.4 | 1.4 | GO:0000791 | euchromatin(GO:0000791) |
1.4 | 8.4 | GO:0071986 | Ragulator complex(GO:0071986) |
1.4 | 19.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.4 | 5.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.4 | 16.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
1.4 | 4.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.4 | 5.5 | GO:0000938 | GARP complex(GO:0000938) |
1.4 | 4.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.4 | 4.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.4 | 6.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.4 | 1.4 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
1.4 | 36.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.4 | 4.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.4 | 2.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.4 | 1.4 | GO:0071953 | elastic fiber(GO:0071953) |
1.4 | 6.8 | GO:0071437 | invadopodium(GO:0071437) |
1.3 | 9.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
1.3 | 28.3 | GO:0015030 | Cajal body(GO:0015030) |
1.3 | 10.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
1.3 | 8.0 | GO:0090543 | Flemming body(GO:0090543) |
1.3 | 11.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.3 | 53.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.3 | 2.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.3 | 14.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.3 | 6.6 | GO:0000812 | Swr1 complex(GO:0000812) |
1.3 | 2.6 | GO:0031143 | pseudopodium(GO:0031143) |
1.3 | 427.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.3 | 26.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.3 | 11.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.3 | 5.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.3 | 5.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.3 | 11.3 | GO:0070852 | cell body fiber(GO:0070852) |
1.3 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.3 | 11.3 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.3 | 11.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.3 | 3.8 | GO:0097255 | R2TP complex(GO:0097255) |
1.2 | 6.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.2 | 8.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.2 | 1.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
1.2 | 14.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.2 | 11.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.2 | 7.4 | GO:0061702 | inflammasome complex(GO:0061702) |
1.2 | 4.9 | GO:0042382 | paraspeckles(GO:0042382) |
1.2 | 6.1 | GO:0005827 | polar microtubule(GO:0005827) |
1.2 | 4.8 | GO:0071797 | LUBAC complex(GO:0071797) |
1.2 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.2 | 26.3 | GO:0055037 | recycling endosome(GO:0055037) |
1.2 | 7.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.2 | 10.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.2 | 20.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
1.2 | 2.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.2 | 5.9 | GO:0016600 | flotillin complex(GO:0016600) |
1.2 | 63.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.2 | 9.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
1.2 | 42.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.2 | 1.2 | GO:0000811 | GINS complex(GO:0000811) |
1.2 | 24.5 | GO:0034451 | centriolar satellite(GO:0034451) |
1.2 | 8.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.2 | 27.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.2 | 3.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.2 | 2.3 | GO:0042585 | germinal vesicle(GO:0042585) |
1.2 | 85.1 | GO:0000793 | condensed chromosome(GO:0000793) |
1.1 | 11.4 | GO:0097225 | sperm midpiece(GO:0097225) |
1.1 | 14.8 | GO:0036038 | MKS complex(GO:0036038) |
1.1 | 14.7 | GO:0005844 | polysome(GO:0005844) |
1.1 | 2.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.1 | 3.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.1 | 1.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.1 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.1 | 1.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.1 | 9.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.1 | 7.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.1 | 5.5 | GO:0000242 | pericentriolar material(GO:0000242) |
1.1 | 1.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.1 | 10.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.1 | 12.9 | GO:0005876 | spindle microtubule(GO:0005876) |
1.1 | 4.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
1.1 | 2.1 | GO:0071817 | MMXD complex(GO:0071817) |
1.1 | 127.5 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.1 | 2.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.1 | 5.3 | GO:0044292 | dendrite terminus(GO:0044292) |
1.1 | 5.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.1 | 5.3 | GO:0060091 | kinocilium(GO:0060091) |
1.1 | 1.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.0 | 22.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
1.0 | 27.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.0 | 2.1 | GO:0030891 | VCB complex(GO:0030891) |
1.0 | 44.5 | GO:0000922 | spindle pole(GO:0000922) |
1.0 | 6.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.0 | 1.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.0 | 10.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
1.0 | 2.1 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.0 | 4.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.0 | 4.1 | GO:0070938 | contractile ring(GO:0070938) |
1.0 | 5.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.0 | 7.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
1.0 | 6.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
1.0 | 8.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.0 | 8.0 | GO:0030904 | retromer complex(GO:0030904) |
1.0 | 2.0 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
1.0 | 1.0 | GO:1990745 | EARP complex(GO:1990745) |
1.0 | 3.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.0 | 1.0 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.0 | 5.8 | GO:0042588 | zymogen granule(GO:0042588) |
1.0 | 10.7 | GO:0097440 | apical dendrite(GO:0097440) |
1.0 | 10.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.0 | 1.0 | GO:1990393 | 3M complex(GO:1990393) |
0.9 | 2.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.9 | 8.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.9 | 7.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.9 | 41.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.9 | 6.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.9 | 16.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.9 | 8.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.9 | 2.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.9 | 168.5 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.9 | 74.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.9 | 88.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.9 | 6.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.9 | 12.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.9 | 7.2 | GO:0005861 | troponin complex(GO:0005861) |
0.9 | 4.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.9 | 57.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.9 | 15.2 | GO:0008305 | integrin complex(GO:0008305) |
0.9 | 8.0 | GO:0043218 | compact myelin(GO:0043218) |
0.9 | 1.8 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.9 | 2.7 | GO:0070069 | cytochrome complex(GO:0070069) |
0.9 | 4.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.9 | 1.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.9 | 3.5 | GO:0098536 | deuterosome(GO:0098536) |
0.9 | 779.3 | GO:0005829 | cytosol(GO:0005829) |
0.9 | 8.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.9 | 0.9 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.9 | 2.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.9 | 10.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.8 | 26.3 | GO:0000776 | kinetochore(GO:0000776) |
0.8 | 9.3 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.8 | 1.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.8 | 8.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.8 | 5.1 | GO:0034464 | BBSome(GO:0034464) |
0.8 | 9.2 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.8 | 2.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.8 | 7.5 | GO:0016235 | aggresome(GO:0016235) |
0.8 | 1.7 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.8 | 25.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.8 | 41.9 | GO:0005694 | chromosome(GO:0005694) |
0.8 | 1133.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.8 | 6.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.8 | 16.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.8 | 8.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.8 | 0.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.8 | 1.6 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.8 | 23.9 | GO:0005938 | cell cortex(GO:0005938) |
0.8 | 2.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 3.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.7 | 638.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.7 | 1.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.7 | 13.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.7 | 25.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.7 | 8.6 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.7 | 6.4 | GO:0043196 | varicosity(GO:0043196) |
0.7 | 2.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.7 | 33.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.7 | 0.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.7 | 1.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.7 | 6.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 7.5 | GO:0030686 | 90S preribosome(GO:0030686) |
0.7 | 3.4 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 15.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.7 | 66.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.6 | 323.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.6 | 4.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.6 | 1.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 3.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.6 | 1.2 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.6 | 58.9 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.6 | 30.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.6 | 2.9 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 4.0 | GO:0016459 | myosin complex(GO:0016459) |
0.6 | 1.1 | GO:0016234 | inclusion body(GO:0016234) |
0.6 | 5.1 | GO:0032040 | small-subunit processome(GO:0032040) |
0.6 | 2.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.6 | 1.1 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.6 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 4.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 4.8 | GO:0031672 | A band(GO:0031672) |
0.5 | 5.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 3.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 0.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.5 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 0.9 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 5.4 | GO:0005902 | microvillus(GO:0005902) |
0.4 | 1.8 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.4 | 6.1 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 25.3 | GO:0031967 | organelle envelope(GO:0031967) |
0.4 | 14.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 15.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.4 | 23.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.4 | 0.4 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.4 | 38.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 15.7 | GO:0005769 | early endosome(GO:0005769) |
0.4 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 10.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 2.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.3 | 0.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.3 | 0.3 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.3 | 7.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 148.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.3 | 1.2 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 50.0 | GO:0005730 | nucleolus(GO:0005730) |
0.3 | 0.3 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 0.3 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.3 | 4.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 4.8 | GO:0005814 | centriole(GO:0005814) |
0.3 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 3.6 | GO:0005819 | spindle(GO:0005819) |
0.2 | 1.7 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 13.6 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.2 | 0.2 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.2 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 3.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.5 | GO:0030496 | midbody(GO:0030496) |
0.1 | 1.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 5.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.0 | GO:0043205 | fibril(GO:0043205) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.7 | 62.7 | GO:0031720 | haptoglobin binding(GO:0031720) |
12.7 | 50.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
11.6 | 46.4 | GO:0009374 | biotin binding(GO:0009374) |
11.4 | 34.1 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
10.4 | 31.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
9.9 | 19.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
9.8 | 49.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
9.4 | 28.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
9.0 | 35.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
8.6 | 25.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
8.4 | 25.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
7.9 | 23.8 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
7.7 | 23.0 | GO:0050692 | DBD domain binding(GO:0050692) |
7.3 | 29.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
7.1 | 70.9 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
7.0 | 28.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
6.7 | 20.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
6.6 | 46.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
6.6 | 39.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
6.6 | 26.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
6.5 | 19.6 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
6.4 | 51.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
6.3 | 31.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
6.2 | 18.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
6.0 | 18.1 | GO:1990188 | euchromatin binding(GO:1990188) |
5.9 | 11.9 | GO:0070538 | oleic acid binding(GO:0070538) |
5.8 | 5.8 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
5.8 | 28.9 | GO:0070061 | fructose binding(GO:0070061) |
5.8 | 23.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
5.7 | 28.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
5.4 | 16.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
5.4 | 27.0 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
5.4 | 32.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
5.3 | 16.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
5.3 | 16.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
5.3 | 15.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
5.3 | 15.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
5.2 | 5.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
5.2 | 26.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
5.0 | 15.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
5.0 | 20.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
5.0 | 35.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
5.0 | 50.3 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
5.0 | 15.0 | GO:0019961 | interferon binding(GO:0019961) |
5.0 | 9.9 | GO:0030519 | snoRNP binding(GO:0030519) |
5.0 | 39.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
4.9 | 14.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
4.8 | 24.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
4.8 | 14.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.8 | 14.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
4.7 | 19.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
4.7 | 4.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
4.7 | 46.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
4.6 | 18.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
4.6 | 13.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.6 | 23.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
4.6 | 13.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
4.6 | 18.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
4.5 | 13.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
4.5 | 17.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
4.5 | 40.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
4.5 | 62.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
4.4 | 13.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
4.4 | 4.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
4.4 | 13.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
4.4 | 4.4 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
4.3 | 8.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
4.3 | 43.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
4.3 | 12.9 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
4.3 | 8.6 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
4.3 | 8.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
4.2 | 16.9 | GO:0015232 | heme transporter activity(GO:0015232) |
4.2 | 20.9 | GO:0035473 | lipase binding(GO:0035473) |
4.1 | 61.9 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
4.1 | 16.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
4.1 | 12.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
4.1 | 36.8 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
4.1 | 12.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
4.1 | 12.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
4.1 | 4.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
4.1 | 4.1 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
4.0 | 12.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
4.0 | 15.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
4.0 | 11.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
4.0 | 4.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
4.0 | 31.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
3.9 | 23.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
3.9 | 27.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
3.9 | 23.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
3.8 | 22.9 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
3.8 | 11.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
3.7 | 11.1 | GO:0008142 | oxysterol binding(GO:0008142) |
3.7 | 11.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
3.6 | 7.3 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
3.6 | 10.9 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
3.6 | 18.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
3.6 | 83.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
3.6 | 10.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
3.6 | 17.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
3.5 | 10.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
3.5 | 21.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
3.5 | 10.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
3.5 | 3.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
3.5 | 10.5 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
3.5 | 31.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
3.5 | 17.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
3.4 | 54.2 | GO:0008143 | poly(A) binding(GO:0008143) |
3.4 | 10.2 | GO:0048030 | disaccharide binding(GO:0048030) |
3.4 | 16.9 | GO:0031013 | troponin I binding(GO:0031013) |
3.4 | 13.5 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
3.4 | 16.9 | GO:0030274 | LIM domain binding(GO:0030274) |
3.4 | 10.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
3.3 | 16.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
3.3 | 10.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.3 | 6.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
3.3 | 63.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
3.3 | 10.0 | GO:0004103 | choline kinase activity(GO:0004103) |
3.3 | 19.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
3.3 | 6.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
3.3 | 13.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
3.2 | 26.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
3.2 | 3.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
3.2 | 9.7 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
3.2 | 9.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
3.2 | 16.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
3.2 | 54.7 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
3.2 | 48.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
3.2 | 16.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
3.2 | 9.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.2 | 19.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
3.1 | 9.4 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
3.1 | 3.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
3.1 | 6.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
3.1 | 15.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
3.1 | 24.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
3.1 | 12.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
3.1 | 9.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
3.1 | 12.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
3.1 | 30.7 | GO:0001846 | opsonin binding(GO:0001846) |
3.1 | 12.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
3.1 | 9.2 | GO:0030984 | kininogen binding(GO:0030984) |
3.0 | 9.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
3.0 | 12.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
3.0 | 3.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
3.0 | 20.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
3.0 | 6.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
3.0 | 35.8 | GO:0017166 | vinculin binding(GO:0017166) |
3.0 | 11.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
3.0 | 14.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
3.0 | 11.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.9 | 20.6 | GO:0000339 | RNA cap binding(GO:0000339) |
2.9 | 5.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
2.9 | 11.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
2.9 | 23.3 | GO:0008430 | selenium binding(GO:0008430) |
2.9 | 20.4 | GO:0046790 | virion binding(GO:0046790) |
2.9 | 34.9 | GO:0044548 | S100 protein binding(GO:0044548) |
2.9 | 43.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
2.9 | 20.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
2.9 | 11.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.9 | 11.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.9 | 11.4 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
2.9 | 14.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.9 | 17.1 | GO:0034817 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
2.9 | 14.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.8 | 2.8 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
2.8 | 16.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
2.8 | 8.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.8 | 30.8 | GO:0071949 | FAD binding(GO:0071949) |
2.8 | 2.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.8 | 2.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
2.8 | 33.3 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.8 | 19.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
2.8 | 30.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
2.7 | 13.7 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
2.7 | 19.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.7 | 11.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
2.7 | 8.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
2.7 | 51.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
2.7 | 8.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
2.7 | 32.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.7 | 21.7 | GO:0034951 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
2.7 | 13.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
2.7 | 8.1 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
2.7 | 35.1 | GO:0010181 | FMN binding(GO:0010181) |
2.7 | 13.5 | GO:0070728 | leucine binding(GO:0070728) |
2.7 | 8.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
2.7 | 67.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
2.7 | 2.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.7 | 48.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
2.7 | 18.7 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
2.7 | 10.6 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
2.6 | 18.5 | GO:0005113 | patched binding(GO:0005113) |
2.6 | 7.9 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
2.6 | 13.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
2.6 | 10.5 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
2.6 | 7.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
2.6 | 5.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
2.6 | 59.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
2.6 | 30.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.6 | 10.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
2.6 | 20.5 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
2.5 | 10.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
2.5 | 10.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
2.5 | 22.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
2.5 | 12.6 | GO:0015288 | porin activity(GO:0015288) |
2.5 | 25.1 | GO:0005536 | glucose binding(GO:0005536) |
2.5 | 15.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
2.5 | 5.0 | GO:0015928 | fucosidase activity(GO:0015928) |
2.5 | 9.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.5 | 7.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
2.5 | 17.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
2.5 | 24.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.5 | 7.4 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
2.4 | 36.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
2.4 | 9.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
2.4 | 36.3 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
2.4 | 4.8 | GO:0034618 | arginine binding(GO:0034618) |
2.4 | 9.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
2.4 | 24.0 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
2.4 | 50.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.4 | 9.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.4 | 49.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
2.3 | 9.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.3 | 14.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
2.3 | 16.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.3 | 18.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
2.3 | 7.0 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.3 | 6.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.3 | 13.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.3 | 18.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.3 | 4.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.3 | 11.5 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
2.3 | 41.2 | GO:0008483 | transaminase activity(GO:0008483) |
2.3 | 9.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.3 | 9.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
2.3 | 6.8 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.3 | 15.8 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
2.2 | 13.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.2 | 6.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.2 | 13.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.2 | 19.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.2 | 68.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.2 | 2.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.2 | 8.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.2 | 15.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
2.2 | 17.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.2 | 37.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
2.2 | 21.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
2.2 | 15.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
2.2 | 32.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
2.2 | 10.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.2 | 8.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.2 | 28.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
2.1 | 10.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.1 | 62.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
2.1 | 27.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.1 | 19.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
2.1 | 6.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.1 | 25.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
2.1 | 6.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
2.1 | 10.6 | GO:0008199 | ferric iron binding(GO:0008199) |
2.1 | 19.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
2.1 | 6.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.1 | 6.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
2.1 | 8.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.1 | 4.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.1 | 4.2 | GO:0043559 | insulin binding(GO:0043559) |
2.1 | 14.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.1 | 6.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.1 | 10.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
2.1 | 18.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.1 | 6.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.1 | 12.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.1 | 22.6 | GO:0019825 | oxygen binding(GO:0019825) |
2.1 | 8.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.0 | 4.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.0 | 18.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
2.0 | 8.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
2.0 | 26.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
2.0 | 4.1 | GO:0089720 | caspase binding(GO:0089720) |
2.0 | 2.0 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
2.0 | 18.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
2.0 | 8.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
2.0 | 18.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.0 | 18.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
2.0 | 2.0 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
2.0 | 6.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.0 | 16.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
2.0 | 6.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
2.0 | 6.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
2.0 | 5.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.0 | 4.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.0 | 57.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
2.0 | 21.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.0 | 3.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
2.0 | 7.8 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.9 | 5.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.9 | 11.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.9 | 3.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.9 | 5.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.9 | 5.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
1.9 | 7.7 | GO:0043515 | kinetochore binding(GO:0043515) |
1.9 | 1.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.9 | 5.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.9 | 3.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.9 | 7.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.9 | 5.7 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
1.9 | 5.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.9 | 11.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
1.9 | 11.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.9 | 3.8 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.9 | 16.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.9 | 11.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.9 | 7.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.9 | 9.3 | GO:0017040 | ceramidase activity(GO:0017040) |
1.9 | 7.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.8 | 1.8 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
1.8 | 48.0 | GO:0015485 | cholesterol binding(GO:0015485) |
1.8 | 12.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.8 | 5.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
1.8 | 12.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.8 | 11.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.8 | 3.7 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.8 | 7.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.8 | 19.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.8 | 3.6 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
1.8 | 19.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.8 | 19.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.8 | 5.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
1.8 | 9.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.8 | 16.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
1.8 | 1.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.8 | 5.4 | GO:0031404 | chloride ion binding(GO:0031404) |
1.8 | 10.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.8 | 1.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.8 | 8.9 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.8 | 24.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.8 | 7.1 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.8 | 5.3 | GO:0004359 | glutaminase activity(GO:0004359) |
1.8 | 1.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.8 | 8.8 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
1.8 | 7.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.8 | 7.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.8 | 17.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.8 | 15.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
1.7 | 1.7 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
1.7 | 7.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.7 | 12.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.7 | 15.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
1.7 | 17.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
1.7 | 3.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.7 | 3.4 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.7 | 8.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.7 | 23.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.7 | 58.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.7 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.7 | 6.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
1.7 | 6.8 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
1.7 | 1.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.7 | 52.3 | GO:0051723 | protein methylesterase activity(GO:0051723) |
1.7 | 10.1 | GO:0070513 | death domain binding(GO:0070513) |
1.7 | 1.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.7 | 8.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.7 | 5.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.7 | 5.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.7 | 1.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.7 | 10.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.7 | 5.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
1.6 | 23.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.6 | 8.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
1.6 | 8.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.6 | 1.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.6 | 4.9 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
1.6 | 44.3 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.6 | 6.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.6 | 1.6 | GO:0008169 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
1.6 | 1.6 | GO:0035276 | ethanol binding(GO:0035276) |
1.6 | 8.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
1.6 | 3.2 | GO:0045340 | mercury ion binding(GO:0045340) |
1.6 | 14.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.6 | 1.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
1.6 | 3.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.6 | 6.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.6 | 25.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.6 | 6.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.6 | 8.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
1.6 | 12.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.6 | 9.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.6 | 1.6 | GO:0004630 | phospholipase D activity(GO:0004630) |
1.6 | 15.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.6 | 28.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.6 | 19.0 | GO:0005542 | folic acid binding(GO:0005542) |
1.6 | 3.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.6 | 262.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
1.6 | 26.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.6 | 4.7 | GO:0009975 | cyclase activity(GO:0009975) |
1.6 | 11.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
1.6 | 6.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.6 | 28.0 | GO:0043531 | ADP binding(GO:0043531) |
1.6 | 3.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.6 | 3.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.5 | 4.6 | GO:0097016 | L27 domain binding(GO:0097016) |
1.5 | 30.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.5 | 4.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.5 | 3.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.5 | 3.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.5 | 9.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.5 | 4.5 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.5 | 6.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.5 | 122.4 | GO:0002020 | protease binding(GO:0002020) |
1.5 | 4.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.5 | 5.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.5 | 20.8 | GO:0005521 | lamin binding(GO:0005521) |
1.5 | 13.3 | GO:0005123 | death receptor binding(GO:0005123) |
1.5 | 62.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
1.5 | 4.4 | GO:0038100 | nodal binding(GO:0038100) |
1.5 | 1.5 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.5 | 7.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.5 | 8.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
1.5 | 4.4 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.5 | 1.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.5 | 32.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.5 | 7.3 | GO:0034046 | poly(G) binding(GO:0034046) |
1.4 | 15.8 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
1.4 | 17.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.4 | 2.9 | GO:0018652 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
1.4 | 4.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.4 | 10.0 | GO:0031996 | thioesterase binding(GO:0031996) |
1.4 | 7.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
1.4 | 9.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
1.4 | 8.4 | GO:0050733 | RS domain binding(GO:0050733) |
1.4 | 2.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.4 | 5.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.4 | 20.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
1.4 | 5.5 | GO:0071253 | connexin binding(GO:0071253) |
1.4 | 1.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
1.4 | 4.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
1.4 | 8.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.4 | 11.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.4 | 4.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.4 | 1.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.4 | 5.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.4 | 15.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
1.4 | 36.7 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
1.4 | 9.5 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.4 | 2.7 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
1.3 | 8.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.3 | 6.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.3 | 8.0 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.3 | 2.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.3 | 10.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.3 | 3.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.3 | 9.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.3 | 11.7 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.3 | 22.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.3 | 9.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.3 | 41.4 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
1.3 | 2.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.3 | 5.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.3 | 15.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.3 | 16.7 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
1.3 | 7.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.3 | 11.6 | GO:0044466 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.3 | 2.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.3 | 21.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.3 | 10.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.3 | 5.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.3 | 24.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
1.3 | 20.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.3 | 5.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.3 | 15.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.3 | 5.1 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.3 | 33.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
1.3 | 1.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.3 | 1.3 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
1.3 | 11.3 | GO:0019215 | intermediate filament binding(GO:0019215) |
1.2 | 5.0 | GO:0019808 | polyamine binding(GO:0019808) |
1.2 | 5.0 | GO:0008494 | translation activator activity(GO:0008494) |
1.2 | 5.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.2 | 4.9 | GO:0038132 | neuregulin binding(GO:0038132) |
1.2 | 3.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.2 | 7.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.2 | 27.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.2 | 3.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.2 | 2.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
1.2 | 6.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.2 | 2.5 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.2 | 4.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.2 | 3.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.2 | 3.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
1.2 | 6.1 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.2 | 3.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.2 | 1.2 | GO:0016015 | morphogen activity(GO:0016015) |
1.2 | 1.2 | GO:0016208 | AMP binding(GO:0016208) |
1.2 | 20.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.2 | 8.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
1.2 | 5.9 | GO:0034916 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
1.2 | 3.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.2 | 109.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.2 | 7.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
1.2 | 10.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.2 | 4.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.2 | 3.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.2 | 7.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.2 | 15.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.2 | 7.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.2 | 3.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.2 | 3.5 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.2 | 9.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.2 | 8.1 | GO:0004177 | aminopeptidase activity(GO:0004177) |
1.1 | 9.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
1.1 | 4.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.1 | 3.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.1 | 13.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.1 | 9.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.1 | 4.5 | GO:1990405 | protein antigen binding(GO:1990405) |
1.1 | 9.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.1 | 13.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.1 | 20.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
1.1 | 79.5 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.1 | 3.4 | GO:0015114 | sodium:phosphate symporter activity(GO:0005436) phosphate ion transmembrane transporter activity(GO:0015114) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.1 | 7.8 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.1 | 10.1 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.1 | 31.3 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
1.1 | 22.3 | GO:0030145 | manganese ion binding(GO:0030145) |
1.1 | 5.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.1 | 1.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.1 | 3.3 | GO:0019862 | IgA binding(GO:0019862) |
1.1 | 6.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.1 | 11.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.1 | 23.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.1 | 5.5 | GO:0000182 | rDNA binding(GO:0000182) |
1.1 | 5.5 | GO:0031491 | nucleosome binding(GO:0031491) |
1.1 | 2.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
1.1 | 6.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.1 | 1.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
1.1 | 1.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
1.1 | 4.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.1 | 2.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
1.1 | 10.8 | GO:0043274 | phospholipase binding(GO:0043274) |
1.1 | 7.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.1 | 5.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
1.1 | 4.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.1 | 4.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.1 | 17.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
1.1 | 4.2 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
1.0 | 41.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
1.0 | 1.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.0 | 6.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.0 | 18.5 | GO:0045502 | dynein binding(GO:0045502) |
1.0 | 10.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
1.0 | 27.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.0 | 10.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
1.0 | 5.1 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
1.0 | 5.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
1.0 | 29.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
1.0 | 8.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.0 | 6.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.0 | 3.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.0 | 6.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.0 | 3.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.0 | 11.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
1.0 | 3.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.0 | 10.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
1.0 | 6.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.0 | 3.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.0 | 3.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 4.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.0 | 2.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.0 | 22.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
1.0 | 1.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.0 | 10.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
1.0 | 4.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.0 | 2.0 | GO:0005534 | galactose binding(GO:0005534) |
1.0 | 2.9 | GO:0019002 | GMP binding(GO:0019002) |
1.0 | 12.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
1.0 | 4.9 | GO:0036122 | BMP binding(GO:0036122) |
1.0 | 11.7 | GO:0019213 | deacetylase activity(GO:0019213) |
1.0 | 1.0 | GO:0031705 | bombesin receptor binding(GO:0031705) |
1.0 | 2.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.0 | 3.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.0 | 18.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
1.0 | 4.8 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.0 | 3.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.0 | 5.8 | GO:0051400 | BH domain binding(GO:0051400) |
1.0 | 8.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
1.0 | 1.0 | GO:0015926 | glucosidase activity(GO:0015926) |
1.0 | 2.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.0 | 169.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
1.0 | 1.0 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
1.0 | 2.9 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.9 | 3.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.9 | 5.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.9 | 5.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.9 | 0.9 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.9 | 1.9 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.9 | 11.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.9 | 2.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.9 | 7.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.9 | 3.7 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.9 | 1.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 1.8 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.9 | 2.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.9 | 1.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.9 | 3.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.9 | 1.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.9 | 1.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.9 | 4.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.9 | 7.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.9 | 0.9 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.9 | 8.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.9 | 53.8 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.9 | 1.7 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.9 | 15.6 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.9 | 0.9 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.9 | 6.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.9 | 21.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.9 | 3.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.9 | 8.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.9 | 6.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 4.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.9 | 1.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.8 | 12.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.8 | 0.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.8 | 2.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.8 | 3.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.8 | 3.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.8 | 8.3 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.8 | 8.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.8 | 3.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.8 | 3.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.8 | 2.5 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.8 | 44.5 | GO:0042626 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.8 | 4.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.8 | 44.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.8 | 3.3 | GO:0004601 | peroxidase activity(GO:0004601) |
0.8 | 24.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.8 | 2.5 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.8 | 77.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.8 | 4.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.8 | 3.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.8 | 20.3 | GO:0042393 | histone binding(GO:0042393) |
0.8 | 1.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 7.3 | GO:0008061 | chitin binding(GO:0008061) |
0.8 | 2.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.8 | 47.6 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
0.8 | 5.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.8 | 3.2 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.8 | 16.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.8 | 4.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.8 | 5.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.8 | 24.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.8 | 18.9 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.8 | 34.6 | GO:0005506 | iron ion binding(GO:0005506) |
0.8 | 1.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.8 | 10.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.8 | 3.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.8 | 1.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.8 | 0.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.8 | 3.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 5.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.8 | 17.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.7 | 6.0 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.7 | 5.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.7 | 19.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.7 | 7.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 1.5 | GO:0050693 | LBD domain binding(GO:0050693) |
0.7 | 13.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.7 | 8.0 | GO:0016829 | lyase activity(GO:0016829) |
0.7 | 7.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.7 | 2.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 70.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.7 | 6.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.7 | 3.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.7 | 2.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.7 | 1.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.7 | 1.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.7 | 1.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.7 | 4.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 1.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 28.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.7 | 2.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 104.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.7 | 19.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.7 | 0.7 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.7 | 22.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.7 | 18.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.7 | 57.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.7 | 7.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 0.7 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.7 | 1.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.7 | 21.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.7 | 8.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.7 | 2.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.7 | 22.9 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.7 | 2.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.7 | 1.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.7 | 2.0 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.7 | 2.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.7 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 0.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.6 | 5.8 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.6 | 12.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.6 | 1.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.6 | 0.6 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.6 | 15.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.6 | 11.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.6 | 11.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.6 | 55.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.6 | 12.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.6 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 2.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.6 | 7.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 2.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.6 | 2.4 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.6 | 55.9 | GO:0051020 | GTPase binding(GO:0051020) |
0.6 | 23.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.6 | 1.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.6 | 4.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.6 | 1.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.6 | 1.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.6 | 1.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.6 | 1.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 3.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.6 | 335.5 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.6 | 4.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.6 | 2.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.6 | 1.7 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 13.0 | GO:0020037 | heme binding(GO:0020037) |
0.6 | 1.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 1.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.6 | 14.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.6 | 7.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 1.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.5 | 0.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.5 | 5.9 | GO:0004527 | exonuclease activity(GO:0004527) |
0.5 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.5 | 0.5 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.5 | 2.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.5 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 1.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.5 | 15.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.5 | 2.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 13.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.5 | 0.5 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.5 | 7.6 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 2.0 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 4.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.5 | 1.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 5.4 | GO:0016918 | retinal binding(GO:0016918) |
0.5 | 13.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.5 | 6.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.5 | 0.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 2.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.5 | 1.0 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.5 | 2.4 | GO:0016886 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.5 | 0.9 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.5 | 1.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 2.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.5 | 1.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.5 | 2.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.4 | 3.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.4 | 1.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 1.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.4 | 1.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 1.8 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 2.6 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.4 | 20.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.4 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.4 | 0.4 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.4 | 5.0 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 0.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.4 | 2.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 6.1 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.4 | 2.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.4 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.4 | 15.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.4 | 0.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 2.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 1.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 16.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.4 | 12.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.4 | 2.0 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.4 | 9.8 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.4 | 5.4 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.4 | 1.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 0.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.4 | 8.9 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.4 | 0.8 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 6.1 | GO:0016874 | ligase activity(GO:0016874) |
0.4 | 6.0 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.4 | 1.5 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 7.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 4.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.4 | 1.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 2.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.3 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 10.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 3.8 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.3 | 13.9 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.3 | 1.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 1.0 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.3 | 1.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 0.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.3 | 1.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 0.3 | GO:0015927 | trehalase activity(GO:0015927) |
0.3 | 1.8 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 0.3 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.3 | 4.8 | GO:0005496 | steroid binding(GO:0005496) |
0.3 | 0.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 33.0 | GO:0008134 | transcription factor binding(GO:0008134) |
0.3 | 0.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.3 | 4.9 | GO:0004519 | endonuclease activity(GO:0004519) |
0.3 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.3 | 2.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 1.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.3 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.3 | 29.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.3 | 0.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 2.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 2.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.3 | 5.8 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 0.5 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 1.8 | GO:0061135 | endopeptidase regulator activity(GO:0061135) |
0.3 | 2.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.5 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.3 | 2.0 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 0.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.2 | 0.5 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 2.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 0.4 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 11.5 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 1.1 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.2 | 0.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.2 | 0.2 | GO:0070697 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.2 | 2.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.2 | GO:0005048 | signal sequence binding(GO:0005048) |
0.2 | 41.1 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 3.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 2.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 2.9 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 1.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 1.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.2 | 6.4 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.2 | 12.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.2 | 4.7 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 0.4 | GO:0090484 | drug transporter activity(GO:0090484) |
0.2 | 0.5 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
0.2 | 18.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 19.2 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.2 | 2.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 5.9 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.6 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 11.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 11.0 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.5 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 4.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 7.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 3.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.2 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 2.3 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.2 | GO:0008266 | poly-pyrimidine tract binding(GO:0008187) poly(U) RNA binding(GO:0008266) |
0.1 | 1.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 12.2 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 70.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 5.9 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.3 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 5.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.8 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 2.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 2.2 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 2.9 | GO:0004175 | endopeptidase activity(GO:0004175) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 5.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
4.8 | 9.7 | ST STAT3 PATHWAY | STAT3 Pathway |
4.7 | 207.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
4.3 | 4.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
4.1 | 70.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
3.9 | 3.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
3.7 | 95.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
3.6 | 54.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
3.4 | 83.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
3.2 | 44.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
3.1 | 40.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
3.1 | 9.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
3.1 | 34.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
3.1 | 43.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
3.0 | 62.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.9 | 8.8 | PID MYC PATHWAY | C-MYC pathway |
2.9 | 2.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
2.8 | 19.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
2.8 | 5.6 | PID IFNG PATHWAY | IFN-gamma pathway |
2.7 | 16.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.7 | 50.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.5 | 22.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.4 | 4.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
2.4 | 122.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.3 | 9.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.3 | 75.7 | PID ARF6 PATHWAY | Arf6 signaling events |
2.3 | 47.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
2.3 | 24.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
2.2 | 44.6 | PID EPO PATHWAY | EPO signaling pathway |
2.2 | 6.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
2.2 | 131.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
2.2 | 28.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
2.2 | 43.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
2.1 | 62.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
2.1 | 80.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
2.1 | 6.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.1 | 2.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
2.1 | 12.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.1 | 2.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
2.1 | 41.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
2.1 | 18.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
2.1 | 32.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
2.0 | 14.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
2.0 | 12.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.9 | 48.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.9 | 63.2 | PID P53 REGULATION PATHWAY | p53 pathway |
1.9 | 70.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.9 | 39.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.9 | 36.0 | PID AURORA A PATHWAY | Aurora A signaling |
1.8 | 12.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.8 | 11.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.8 | 16.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
1.8 | 67.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.8 | 3.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.7 | 12.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.7 | 5.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.7 | 27.3 | ST GAQ PATHWAY | G alpha q Pathway |
1.7 | 74.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.7 | 5.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.7 | 30.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.7 | 5.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
1.7 | 10.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.7 | 21.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.6 | 49.1 | PID P73PATHWAY | p73 transcription factor network |
1.6 | 24.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.6 | 127.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.6 | 42.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.6 | 46.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.5 | 4.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.5 | 42.4 | PID PLK1 PATHWAY | PLK1 signaling events |
1.5 | 11.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.4 | 31.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.4 | 11.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.4 | 2.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
1.4 | 10.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.4 | 8.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.4 | 20.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.3 | 17.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.3 | 6.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
1.3 | 13.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.3 | 6.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
1.2 | 19.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.2 | 5.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.2 | 17.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
1.2 | 7.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.2 | 25.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.2 | 9.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.1 | 3.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.1 | 32.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.1 | 11.1 | PID ATM PATHWAY | ATM pathway |
1.1 | 19.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.1 | 14.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.1 | 12.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.1 | 9.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.1 | 10.9 | PID ALK2 PATHWAY | ALK2 signaling events |
1.1 | 8.7 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.1 | 4.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.1 | 10.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.1 | 3.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
1.1 | 17.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.1 | 12.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.1 | 15.9 | PID ATR PATHWAY | ATR signaling pathway |
1.0 | 17.8 | PID BCR 5PATHWAY | BCR signaling pathway |
1.0 | 10.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.0 | 21.0 | PID E2F PATHWAY | E2F transcription factor network |
0.9 | 27.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.9 | 11.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.8 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 12.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.8 | 21.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.8 | 9.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.8 | 1.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.8 | 11.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.8 | 1.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 6.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.8 | 6.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.8 | 16.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.8 | 15.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 7.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.7 | 9.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.6 | 121.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 7.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.6 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 8.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 11.5 | PID BMP PATHWAY | BMP receptor signaling |
0.5 | 9.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 4.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.5 | 5.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.5 | 3.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 4.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 0.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.4 | 5.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.4 | 2.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 3.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.4 | 1.8 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 2.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 3.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 1.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 1.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.3 | 6.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 2.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 2.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 7.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 3.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 3.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 0.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 24.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 0.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 18.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.1 | 145.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
7.1 | 70.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
7.0 | 7.0 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
6.0 | 77.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
5.6 | 62.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
5.4 | 10.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
5.4 | 42.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
5.1 | 5.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
5.0 | 55.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
5.0 | 50.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
4.4 | 22.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
4.2 | 46.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
4.2 | 20.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
4.1 | 40.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
4.0 | 43.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
3.9 | 11.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
3.8 | 115.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
3.7 | 63.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
3.7 | 40.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
3.7 | 36.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
3.6 | 10.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.6 | 90.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
3.6 | 35.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
3.5 | 98.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
3.5 | 21.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
3.5 | 58.7 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
3.4 | 34.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.4 | 33.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
3.4 | 43.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
3.3 | 6.7 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
3.1 | 12.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
3.1 | 53.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
2.9 | 26.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.8 | 34.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
2.8 | 64.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.8 | 25.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
2.8 | 27.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
2.8 | 44.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
2.8 | 30.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
2.7 | 62.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
2.6 | 15.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
2.6 | 124.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
2.6 | 31.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
2.6 | 13.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.6 | 70.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
2.6 | 33.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.5 | 38.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
2.5 | 12.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
2.5 | 9.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
2.5 | 31.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.4 | 33.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.4 | 12.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
2.4 | 11.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.3 | 7.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
2.3 | 35.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
2.3 | 30.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
2.3 | 46.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
2.3 | 41.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
2.3 | 16.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
2.3 | 29.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.3 | 24.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
2.3 | 31.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.3 | 56.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
2.2 | 24.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.2 | 55.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
2.2 | 24.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
2.2 | 96.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
2.2 | 2.2 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
2.2 | 43.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.1 | 19.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.1 | 23.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
2.1 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
2.1 | 21.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
2.1 | 52.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
2.1 | 37.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.1 | 20.7 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
2.0 | 41.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
2.0 | 4.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
2.0 | 50.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
2.0 | 28.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
2.0 | 4.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
2.0 | 46.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
2.0 | 4.0 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
2.0 | 52.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
2.0 | 46.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
2.0 | 8.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
2.0 | 27.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.0 | 33.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.9 | 3.8 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
1.9 | 11.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.9 | 15.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
1.9 | 43.3 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
1.9 | 5.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.8 | 20.3 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
1.8 | 1.8 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
1.8 | 11.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.8 | 20.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.8 | 12.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.8 | 153.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.8 | 10.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.8 | 99.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.7 | 7.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.7 | 12.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.7 | 22.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.7 | 13.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.7 | 130.1 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.7 | 13.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.7 | 10.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.7 | 3.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.7 | 6.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.7 | 6.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.6 | 16.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.6 | 3.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.6 | 27.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.6 | 6.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.6 | 16.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.6 | 54.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
1.6 | 44.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.6 | 46.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
1.6 | 1.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.6 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.5 | 6.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.5 | 7.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.5 | 37.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.5 | 10.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.5 | 1.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
1.5 | 1.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
1.5 | 14.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.5 | 7.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.5 | 5.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.4 | 30.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.4 | 25.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.4 | 7.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.4 | 1.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.4 | 13.8 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
1.4 | 13.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.4 | 10.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.4 | 10.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.4 | 1.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.4 | 2.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.3 | 14.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.3 | 1.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.3 | 30.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.3 | 14.2 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.3 | 19.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.3 | 2.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.3 | 1.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
1.3 | 10.1 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.3 | 3.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
1.3 | 15.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.2 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.2 | 13.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.2 | 8.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.2 | 19.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.2 | 2.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
1.2 | 130.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.2 | 16.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.2 | 11.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.2 | 13.1 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
1.2 | 68.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.2 | 23.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
1.2 | 17.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
1.2 | 8.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.2 | 10.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.1 | 4.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
1.1 | 29.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
1.1 | 36.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.1 | 33.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.1 | 9.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.1 | 5.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.1 | 13.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
1.1 | 10.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.1 | 92.2 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.1 | 61.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.1 | 14.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
1.1 | 2.2 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
1.0 | 20.3 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.0 | 86.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
1.0 | 29.2 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
1.0 | 18.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.9 | 0.9 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.9 | 8.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.9 | 26.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 17.9 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.9 | 12.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.9 | 5.2 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.9 | 41.5 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.9 | 12.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 19.4 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.8 | 1.6 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.8 | 1.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.8 | 7.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.8 | 7.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.8 | 0.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.8 | 3.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.8 | 32.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.8 | 11.6 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.7 | 6.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.7 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.7 | 8.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.7 | 24.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.7 | 3.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.7 | 73.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.6 | 7.1 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.6 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 14.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.6 | 21.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.6 | 5.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.6 | 1.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.6 | 19.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.6 | 12.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 11.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.6 | 2.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.6 | 6.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.5 | 33.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 0.5 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.5 | 21.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.5 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.5 | 5.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 5.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.5 | 2.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.5 | 3.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.4 | 3.9 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 0.4 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.4 | 4.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.4 | 8.2 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.4 | 1.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.3 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 5.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.3 | 0.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 1.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 8.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.3 | 4.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 1.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 7.0 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 2.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 21.7 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 1.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.2 | 3.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 0.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 2.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 4.7 | REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION | Genes involved in Post-translational protein modification |
0.2 | 0.2 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.7 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 0.8 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.1 | 2.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |